Document:

TRANSITION AGREEMENT AND RELEASE

  

  

  This Transition Agreement and Release (“Transition Agreement”) is entered into by and between Jason Green
    (“Executive”) and National Instruments Corporation (“Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) as of the Effective Date (as defined below).

  

  

  RECITALS

  

  

  WHEREAS, Executive is employed at-will by the Company;

  

  

  WHEREAS, Executive entered into an Executive Employment Agreement and accompanying At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (“Confidentiality
    Agreement”) with the Company on or about February 22, 2021, which is attached hereto as Exhibit A;

  WHEREAS, the Company has granted Executive service-based restricted stock unit awards and
    performance-based restricted stock unit awards covering shares of the Company’s common stock (the “Equity Awards”), pursuant to the terms and conditions of the applicable Company equity plan and award agreements thereunder (collectively, the “Equity
    Documents”);

  

  

  WHEREAS, the Parties desire that Executive begin transitioning his role as of November 15, 2022 (the “Transition
    Date”) and provide transition duties as requested by the Company through December 31, 2022 (the “Separation Date”);

  

  

  WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions,
    petitions, and demands that the Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive’s employment with or separation from
    the Company.

  

  

  NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as
    follows:

   

  

  COVENANTS

  1. Consideration.  In consideration of
      Executive’s execution of this Transition Agreement, and contingent upon Executive’s fulfillment of all of the terms and conditions set forth herein, and provided Executive does not revoke this Transition Agreement under Section 6 below, the Company
      agrees as follows:

  a. Continued Employment During
        Transition Period.  Upon the Transition Date, Executive will be expected to perform transition duties as requested by the Company through the Separation Date (the period between the Transition Date and the Separation Date shall be referred
      to as the “Transition Period”). Executive agrees that during the Transition Period, Employee will remain cooperative with the Company and its executive leadership in good faith and will continue to materially comply with all Company policies as well
      as his obligations under this Agreement, including, but not limited to, his non-disparagement obligations in Section 10 below.  The Company will continue to pay Executive’s base salary at his current rate until the Separation Date, less applicable
      withholdings, and in accordance with the Company’s regular payroll practices.  Executive’s other Company employee benefits shall continue during the Transition Period, subject to the terms of the applicable policies and plans.  Executive also shall
      continue to vest under any applicable Equity Award grants during the Transition Period, subject to the terms and conditions of any applicable Equity Documents.

  b. Separation Agreement and Release.
      The Parties understand and agree that upon completion of the Transition Period, Executive will be eligible for the benefits offered under the Separation Agreement and Release (“Separation Agreement”) attached hereto as Exhibit B; provided that Executive signs and does not revoke the Separation Agreement and that such agreement becomes effective under its terms. Executive acknowledges and agrees that he
      has received adequate consideration pursuant to this Transition Agreement and the Separation Agreement attached hereto, and Executive agrees to execute the Separation Agreement on or after the Separation Date.  Executive further agrees that continued
      employment during the Transition Period, as well as the payment of salary and the provision of benefits during the Transition Period, are expressly conditioned upon his agreement to execute the Separation Agreement on or after the Separation Date. 
      Executive acknowledges and agrees that any benefits or consideration offered under the Separation Agreement are expressly conditioned upon Executive signing that agreement, and such agreement becoming effective under its terms.

  
    
      1

    

    
      

  

  
  c. Transition Services. The
      Company agrees to provide Executive a payment of Ten Thousand Dollars and No Cents ($10,000.00) to be used for Executive to retain executive transition outplacement services through a provider of his choosing. This payment will be made to Executive
      within ten (10) business days after the Effective Date of this Transition Agreement.

  d. Acknowledgement. Executive
      acknowledges that without this Transition Agreement, Executive is otherwise not entitled to the consideration listed in this Section 1.

  

  

  2. Equity Awards.  The Parties agree that for purposes of
      determining the number of shares of the Company’s common stock that Executive is entitled to receive from the Company, pursuant to the vesting of outstanding Equity Awards, Executive will be considered to have vested only up to the Separation Date; provided, however, that Executive is eligible for acceleration of
      vesting of certain Equity Awards subject to service-based vesting as set forth in Section 1(c) of the Separation Agreement.  For the avoidance of any doubt, Executive’s PRSU (performance RSUs) vesting set in December 2022 will be awarded provided
      that Executive fulfills the conditions of this Transition Agreement, including but not limited to, his obligations under Section 1(a) above. All unvested shares subject to outstanding Equity Awards as of the Separation Date will terminate on the
      Separation Date (excluding, for avoidance of doubt, any shares for which vesting is accelerated under Section 1(c) of the Separation Agreement). Other than as set forth in Section 1(c) of the Separation Agreement, the Equity Awards shall continue to
      be governed by the terms and conditions of the Equity Documents.

  

  

  3. Payment of Salary and Receipt of All Benefits. 
      Executive acknowledges and represents that, other than the consideration set forth in this Transition Agreement and the Separation Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, premiums,
      leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, vesting, and any and all other benefits and compensation that may be due to Executive.

  

  

  4. Release of Claims.  Executive agrees that the foregoing
      consideration represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit
      plans, plan administrators, professional employer organizations or co-employers, insurers, trustees, divisions, subsidiaries, predecessor and
      successor corporations, and assigns (collectively, “Releasees”). Executive, on his behalf and on behalf of his respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue
      concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that
      Executive may possess against any Releasee arising from any omissions, acts, facts, or damages occurring up until and including the date Executive signs this Transition Agreement, including, without limitation:

  

  

  a. any and all claims relating to or arising from Executive’s employment relationship with the Company and the termination of that relationship;

  
    
      2

    

    
      

  

  
  b. any and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of shares of stock of the Company, including,
      without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

  

  

  c. any and all claims for wrongful discharge of employment, termination in violation of public policy, discrimination, harassment, retaliation, breach
      of contract (both express and implied), breach of covenant of good faith and fair dealing (both express and implied), promissory estoppel, negligent or intentional infliction of emotional distress, fraud, negligent or intentional misrepresentation,
      negligent or intentional interference with contract or prospective economic advantage, unfair business practices, defamation, libel, slander, negligence, personal injury, assault, battery, invasion of privacy, false imprisonment, conversion, and
      disability benefits;

  

  

  d. any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of
      1964, the Civil Rights Act of 1991, the Rehabilitation Act of 1973, the Americans with Disabilities Act of 1990, the Equal Pay Act, the Fair Labor Standards Act, the Fair Credit Reporting Act, the Age Discrimination in Employment Act of 1967, the
      Older Workers Benefit Protection Act, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining Notification Act, the Family and Medical Leave Act, the Immigration Reform and Control Act, the National Labor Relations
      Act, the Texas Payday Act, the Texas Workers’ Compensation Act, and Chapter 21 of the Texas Labor Code (also known as the Texas Commission on Human Rights Act);

  

  

  e. any and all claims for violation of the federal or any state constitution;

  

  

  f. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;

  

  

  g. any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the proceeds
      received by Executive as a result of this Transition Agreement; and

  

  

  h. any and all claims for attorneys’ fees and costs.

  

  

  Executive agrees that the release set forth in this Section shall be and remain in effect in all respects as a complete general release
    as to the matters released. Notwithstanding anything to the contrary herein, this Transition Agreement does not waive or release any rights or claims Executive may have to indemnification, defense, advancement, or insurance coverage under Executive’s
    Indemnification Agreement dated August 25, 2020 (the “Indemnification Agreement”) or any law, regulation, bylaw, article of incorporation, or insurance policy. This release does not extend to any obligations incurred under this Transition Agreement.
    This release does not release claims that cannot be released as a matter of law. Any disputed wage claims that are released herein shall be subject to binding arbitration in accordance with this Transition Agreement, except as required by applicable
    law. This release does not extend to any right Executive may have to unemployment compensation benefits.

  

  

  5. Acknowledgment of Waiver of Claims under ADEA. 
      Executive acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Executive agrees that this waiver and release
      does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Transition Agreement.  Executive acknowledges that the consideration given for this waiver and release is in addition to anything of value to which
      Executive was already entitled. Executive further acknowledges that he has been advised by this writing that: (a) he should consult with an attorney prior to
      executing this Transition Agreement; (b) he has twenty-one (21) days within which to consider this Transition Agreement; (c) he has seven (7) days following his execution of this Transition Agreement to revoke this Transition Agreement; (d) this
      Transition Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Transition Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this
      waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Transition Agreement and returns it to the Company in less than the
      21-day period identified above, Executive hereby acknowledges that he has freely and voluntarily chosen to waive the time period allotted for considering this Transition Agreement. Executive acknowledges and understands that revocation must be
      accomplished by a written notification to the Company’s Chief Executive Officer with a copy to its General Counsel that is received prior to the Effective
      Date. The Parties agree that changes to this Transition Agreement, whether material or immaterial, do not restart the running of the 21-day consideration period referenced above.

  
    
      3

    

    
      

  

  6. Unknown Claims. Executive acknowledges that he has been
      advised to consult with legal counsel and that he is familiar with the principle that a general release does not extend to claims that the Executive does not know or suspect to exist in his favor at the time of executing the release, which, if known
      by him, must have materially affected his settlement with the releasee. Executive, being aware of said principle, agrees to expressly waive any rights he may have to that effect, as well as under any other statute or common law principles of similar
      effect.

  

  

  7. Non-Competition, Non-Solicitation, Non-Interference, and
          Confidential Information.  Executive reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreement, a copy of which is enclosed with this Transition Agreement as Exhibit A, specifically including the provisions therein regarding non-disclosure of the Company’s trade secrets and confidential and proprietary information, and Executive’s non-competition,
      non-solicitation, and non-interference obligations. Executive hereby grants consent to notification by the Company to any new employer about his obligations under the
        Confidentiality Agreement and this Section.  The Company hereby grants Executive consent to notify bona fide prospective and actual employers or business partners of his obligations under the Confidentiality Agreement and this Section.

  

  

  8. No Cooperation.  Subject to the Protected Activity
      Section below, Executive agrees that he will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party
      against any of the Releasees, unless under a subpoena or other court order to do so or upon written request from an administrative agency or the legislature or as related directly to the ADEA waiver in this Transition Agreement. Executive agrees both
      to promptly notify the Company upon receipt of any such subpoena or court order or written request from an administrative agency or the legislature, and to furnish, within five (5) business days of its receipt, a copy of such subpoena or other court
      order or written request from an administrative agency or the legislature. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of
      the Releasees, Executive shall state no more than that he cannot provide counsel or assistance.

  

  

  9. Protected Activity Not Prohibited.  Executive
      understands that nothing in this Transition Agreement, or any other agreement or policy of the Company, shall in any way limit or prohibit Executive from engaging in
      any Protected Activity. Protected Activity includes filing and/or pursuing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by any federal, state,
      or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and
      Health Administration, and the National Labor Relations Board (“Government Agencies”). Executive understands that in connection with such Protected Activity, he is permitted to disclose documents or other information as permitted by law, without
      giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company
      Confidential Information under the Confidentiality Agreement to any parties other than the Government Agencies. Executive further understands that “Protected Activity” does not include the disclosure of any Company attorney-client privileged
      communications or attorney work product.

  
    
      4

    

    
      

  

  
  10. Mutual Nondisparagement. Executive agrees to refrain
      from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees. The Company agrees to refrain from making any
      disparaging statements about Executive. Executive understands that the Company’s obligations under this Section extend only to the Company’s current executive officers and members of its Board of Directors and only for so long as each officer or
      member is an employee or Director of the Company.

  

  

  11. No Admission of Liability.  Executive understands and
      acknowledges that with respect to all claims released herein, this Transition Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive unless such claims were explicitly not released by the
      release in this Transition Agreement. No action taken by the Company hereto, either previously or in connection with this Transition Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential
      claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.

  

  

  12. Costs.  The Parties shall each bear their own costs,
      attorneys’ fees, and other fees incurred in connection with the preparation of this Transition Agreement.

  

  

  13. ARBITRATION.  EXCEPT AS PROHIBITED BY LAW, THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS TRANSITION AGREEMENT, THEIR INTERPRETATION, EXECUTIVE’S EMPLOYMENT WITH THE COMPANY OR THE
        TERMS THEREOF, OR ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION UNDER THE FEDERAL ARBITRATION ACT (THE “FAA”) AND THAT THE FAA SHALL GOVERN AND APPLY TO THIS ARBITRATION AGREEMENT WITH FULL FORCE AND EFFECT; HOWEVER,
      WITHOUT LIMITING ANY PROVISIONS OF THE FAA, A MOTION OR ACTION TO COMPEL ARBITRATION MAY ALSO BE BROUGHT IN STATE COURT UNDER THE PROCEDURAL PROVISIONS OF SUCH STATE’S LAWS RELATING TO MOTIONS OR ACTIONS TO COMPEL ARBITRATION. EXECUTIVE AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, EXECUTIVE MAY BRING ANY SUCH ARBITRATION PROCEEDING ONLY IN EXECUTIVE’S INDIVIDUAL CAPACITY. THE PARTIES AGREE THAT ANY
      AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS TRANSITION AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN TRAVIS COUNTY, TEXAS BEFORE JUDICIAL ARBITRATION & MEDIATION SERVICES, INC.
      (“JAMS”), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (“JAMS RULES”). THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES. THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH TEXAS LAW,
      INCLUDING THE TEXAS RULES OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL TEXAS LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION. TO THE EXTENT THAT THE JAMS RULES
      CONFLICT WITH TEXAS LAW, TEXAS LAW SHALL TAKE PRECEDENCE. THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION.  THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO
      INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD. THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS
      RESPECTIVE COUNSEL FEES AND EXPENSES.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM
      SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS TRANSITION AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD
      ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS SECTION CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.

  
    
      5

    

    
      

  

  
  14. Tax Consequences.  The Company makes no representations
      or warranties with respect to the tax consequences of the payments and any other consideration provided to Executive or made on Executive’s behalf under the terms of this Transition
      Agreement. Executive agrees and understands that Executive is responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments
      thereon. Executive further agrees to indemnify and hold the Releasees harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts
      claimed due on account of (a) Executive’s failure to pay or delayed payment of international, federal, or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs.

  

  

  15. Authority.  The Company represents and warrants that the
      undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Transition Agreement. Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Transition Agreement. Each Party warrants and
      represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

  

  

  16. Severability.  In the event that any provision or any
      portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Transition Agreement shall continue in full force and
      effect without said provision or portion of provision.

  

  

  17. Attorneys’ Fees.  Except with regard to a legal action
      challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Transition Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in
      connection with such an action.

  

  

  18. Entire Agreement. This Transition Agreement represents the
        entire agreement and understanding between the Company and Executive concerning the subject matter of this agreement and Executive’s continued employment with the Company during the Transition Period and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and
      understandings concerning the subject matter herein and Executive’s relationship with the Company, with the exception of the Confidentiality Agreement and the Equity Agreements.  Notwithstanding anything to the contrary herein, this Transition Agreement does not supersede or replace the Indemnification Agreement or any law, bylaw, article of incorporation or insurance policy that provides Executive a right
      to indemnification, defense, advancement, or insurance coverage.

  

  

  19. No Oral Modification.  This Transition Agreement may
      only be amended in a writing signed by Executive and the Company’s Chief Executive Officer.

  

  

  20. Governing Law.  This Transition Agreement shall be
      governed by the laws of the State of Texas, without regard for choice-of-law provisions, except that any dispute regarding the enforceability of the Arbitration Section of
        this Transition Agreement shall be governed by the FAA. Executive
      consents to personal and exclusive jurisdiction and venue in the State of Texas.

  
    
      6

    

    
      

  

  21. Effective Date.  Executive understands that this Transition Agreement shall be null and void if not executed by Executive within twenty-one (21) days. Each Party has seven (7) days after that Party signs this Transition Agreement to revoke it. This Transition Agreement will become effective on the eighth (8th) day after Executive signed this Transition Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”).

  

  

  22. Counterparts.  This Transition Agreement may be executed
      in counterparts and each counterpart shall be deemed an original and all of which counterparts taken together shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the
      undersigned.  The counterparts of this Transition Agreement may be executed and delivered by facsimile, photo, email PDF, or other electronic transmission or signature.

  

  

  28. Voluntary Execution of Agreement.  Executive understands and agrees that he executed this Transition Agreement voluntarily and without any duress or undue influence on the part or behalf of the Company or
      any third party, with the full intent of releasing all of Executive’s claims against the Company and any of the other Releasees. Executive acknowledges that: (a) he has read this Transition Agreement; (b) he has been represented in the
      preparation, negotiation, and execution of this Transition Agreement by legal counsel of Executive’s own choice or has elected not to retain legal counsel; (c) he
      understands the terms and consequences of this Transition Agreement and of the releases it contains; (d) he is fully aware of the legal and binding effect of this Transition Agreement; and (e) has not relied upon any representations or statements
      made by the Company that are not specifically set forth in this Transition Agreement.

  
    
      7

    

    
      

  

  
  IN WITNESS WHEREOF, the Parties have executed this Transition Agreement on the respective dates set forth below.

   

  

  

  

  
    	
             

          	
            JASON GREEN, an individual

          
	
             

          	
             

          
	
            Dated: Nov 14, 2022

          	
            /s/ Jason Green

          	
             

          

    

    

    

    

    

    

    

    

    	 	
             

          	
            NATIONAL INSTRUMENTS CORPORATION

          
	 	
             

          	
             

          
	
            Dated: Nov 14, 2022

          	
            By:

          	
            /s/ Eric Starkloff

          	
             

          
	 	
             

          	
            Eric Starkloff

            Chief Executive Officer

          

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  Signature Page to Transition Agreement

  
    
      8

    

    
      

  

  
   

  

  EXHIBIT A: To the Transition Agreement and Release

    

  

  

  Copy of Executive’s Executive Employment Agreement and Accompanying Confidentiality Agreement

  
    
      9

    

    
      

  

  
    

    

    NATIONAL INSTRUMENTS CORPORATION

    EXECUTIVE EMPLOYMENT AGREEMENT

    This Employment Agreement (this “Agreement”) by and between Jason Green (“Executive”) and
      National Instruments Corporation (“Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) is dated to be effective as of February 22, 2021 (the “Effective Date”).

    RECITALS

    WHEREAS, the Company currently employs Executive as Chief Revenue Officer and Executive Vice
      President, Portfolio BU and seeks to enter into an agreement embodying the terms of such continuing employment; and

    WHEREAS, Executive desires to accept such continuing employment and enter into such an
      agreement.

    NOW, THEREFORE, in consideration of the mutual promises made herein, the
      Company and Executive hereby agree as follows:

    AGREEMENT

    1. Duties and Scope of Employment.

    (a) Positions and Duties.  As
        of the Effective Date, Executive will continue to serve as Chief Revenue Officer and Executive Vice President, Portfolio BU and continue reporting to the Company’s Chief Executive Officer and President, Eric Starkloff (“Manager”).  Executive will
        render such business and professional services in the performance of his duties, consistent with Executive’s position within the Company, as shall reasonably be assigned to him by his Manager.  The period of Executive’s employment under this
        Agreement is referred to herein as the “Employment Period.”

    (b) Obligations.  During the
        Employment Period, Executive will perform his duties faithfully and to the best of his ability and will devote his full business efforts and time to the Company.  For the duration of the Employment Period, Executive agrees not to engage in any
        other employment, occupation, or consulting activity for any direct or indirect remuneration without his Manager’s prior written approval and subject to the approvals required by the Conflict of Interest Policy for employees of the Company.

    2. At-Will Employment. 
        The Parties agree that Executive’s employment with the Company will continue to be at-will employment and therefore may be terminated at any time with or without cause or notice, for any reason or no reason.  However, as described in this
        Agreement, Executive may be entitled to severance benefits depending on the circumstances of Executive’s termination of employment with the Company.  The Company requests that, in the event of Executive’s resignation, where practicable, Executive
        provide the Company with up to ninety (90) days’ advance notice.  The Company may, in its discretion, accelerate the separation date during that period without altering the nature of Executive’s resignation.  Any such requested notice period does
        not alter the at-will nature of Executive’s employment with the Company.

    3. Compensation.

    (a) Base Salary.  As of the
        Effective Date, Executive’s annual base salary will remain at a rate of Five Hundred Seventy-Five Thousand Dollars ($575,000) per annum payable in accordance with the Company’s normal payroll practices and subject to usual required withholdings.  The term “Base Salary” means the greater of a rate of Five Hundred Seventy-Five Thousand Dollars ($575,000) per annum or such greater, but not lower, rate of pay the
        Company might hereafter set for Executive.  The first and last payment of Executive’s Base Salary will be adjusted, if necessary, to reflect a commencement or termination date other than the first or last working day of a pay period.

    
      
        

    

    
    (b) Annual Bonus.  As of the
        Effective Date, Executive is eligible to participate in the Company Executive Incentive Program (“EIP”) with an annual target of eighty percent (80%) of Base Salary, with performance goals commensurate with Executive’s position, as specified by the
        Compensation Committee of the Board of Directors (the “Committee”) from time to time, as may be applicable.  The actual earned EIP bonus will be determined based on achievement of performance goals and paid no later than two and one-half (2-1/2)
        months following the end of the performance year.

    (c) Restricted Stock Unit Award. 

        Pursuant to action by the Committee on January 19, 2021, Executive was granted restricted stock units with a grant dollar value of One Million Six Hundred Thousand Dollars ($1,600,000) (the “RSU Award”).  One-half of the restricted stock units
        subject to the RSU Award will be scheduled to vest annually over three (3) years subject to Executive’s continued service as an employee through each vesting date.  The remaining restricted stock units subject to the Initial Award will vest based
        on the Company’s total shareholder return performance in relation to the performance of the Russell 2000 index over a three (3)-year period commencing January 1, 2021 and subject further to Executive’s continued employment through the vesting
        date.  The RSU Award will be subject to the terms of the Company’s 2020 Equity Incentive Plan or a successor plan, as applicable, and to the standard approved form of service-based and performance-based restricted stock unit agreement thereunder
        (the “Equity Award Documents”) and to Executive’s continued employment through the award grant date.  Executive understands and agrees that, to the extent he becomes eligible for any future equity grants, such grant would be subject to any required
        Committee approval and subject to the relevant equity documents as then in effect at the Company.

    4. Employee Benefits.  During the
        Employment Period, Executive and Executive’s eligible dependents will continue to be eligible to participate in Company employee benefit plans and perquisites and fringe benefit programs, including medical, dental, 401(k), and Company stock
        purchase plan, made available to other senior executive-level employees, as in effect from time to time.

    5. Vacation.  During the Employment
        Period, Executive will be entitled to paid vacation in accordance with the Company’s then-current policy for other executive-level employees.

    6. Severance Benefits.

    (a) Termination Without Cause or
            Resignation for Good Reason.  If the Company terminates Executive’s employment involuntarily without Cause (excluding any termination due to death or Disability) or Executive resigns for Good Reason, then, subject to the limitations
        of Sections 7 and 8 below, Executive shall be entitled to receive: (i) continuing severance pay at a rate equal to one hundred percent (100%) of the Executive’s Base Salary, as then in effect (less applicable withholding), for a period of twelve
        (12) months from the date of such termination, paid in accordance with the Company’s normal payroll practices; (ii) to the extent not already earned and accrued, a lump sum equivalent to one hundred percent (100%) of Executive’s EIP bonus as in
        effect at the time of the applicable termination or resignation, less applicable withholding, which amount shall be paid at such time annual bonuses are paid to other senior executives of the Company (for avoidance of doubt in no case would
        Executive be entitled to more than one EIP bonus payment under the terms of this provision); (iii) accelerated vesting of Executive’s outstanding Company service-based restricted stock units that would have vested had Executive remained employed by
        the Company for twelve (12) months following the termination date, and subject to any required approval by the Committee, such approval not to be unreasonably withheld; and (iv) provided Executive timely elects healthcare continuation coverage
        under the Consolidated Omnibus Budget Reconciliation Act of 1986 (“COBRA”), Company reimbursement of Executive for, or direct payment of, Executive’s COBRA premiums (at the coverage level in effect immediately prior to Executive’s termination)
        until the earlier of twelve (12) months following the termination date or the date Executive becomes covered under similar plans.  If the Company determines, in its sole discretion, that it cannot provide the foregoing benefit related to COBRA
        premiums without potentially violating, or being subject to an excise tax under, applicable law, the Company will instead provide a taxable monthly payment of an equivalent amount, which will be made regardless of whether Executive elects COBRA and
        continue until the earlier of twelve (12) months following termination or the date Executive becomes covered under similar plans.

    
      2

      
        

    

    
    (b) Change in Control Benefits. 

        Notwithstanding any contrary provision in the preceding paragraph, if a termination described in Section 6(a) occurs within the period beginning three (3) months prior to a Change in Control and ending twelve (12) months following a Change in
        Control, then the Executive will be entitled to receive the same severance in Section 6(a) except the severance amount in Section 6(a)(i) will be paid in a lump-sum on the sixtieth (60th) day following the termination date.  For
        avoidance of doubt, Executive’s equity awards will remain subject to the Change in Control vesting or other treatment as provided for under the terms of the Company’s equity plan and Executive’s equity award agreements, as applicable,
        notwithstanding Executive’s eligibility to receive vesting acceleration under Section 6(a)(iii) of this Agreement in the event of a termination described in Section 6(a).

    (c) Voluntary Resignation; Termination
            for Cause.  If Executive’s employment with the Company or its Affiliates (as defined below) terminates (i) voluntarily by Executive (other than for Good Reason) or (ii) for Cause by the Company, then Executive will not be entitled to
        receive severance or other benefits except for those (if any) as may then be established under the Company’s then existing severance and benefits plans and practices or pursuant to other written agreements with the Company, if applicable.

    (d) Disability; Death.  If
        the Company terminates Executive’s employment as a result of Executive’s Disability, or Executive’s employment terminates due to Executive’s death, then Executive will not be entitled to receive severance or other benefits except for those (if any)
        as may then be established under the Company’s then existing written severance and benefits plans and practices or pursuant to other written agreements with the Company, if applicable.

    (e) Accrued Compensation. 
        For the avoidance of any doubt, in the event of a termination of Executive’s employment with the Company or its Affiliates, Executive will be entitled to receive all accrued but unpaid base salary, any earned but unused vacation pay, and
        reimbursement for any unreimbursed expenses, in accordance with Company policies then in effect and applicable law.

    (f) Transfer between the Company and
            Affiliates.  For purposes of this Section 6, Executive will not be determined to have been terminated without Cause, where Executive continues to remain employed by the Company or one of its Affiliates (e.g., upon transfer from on
        Affiliate to another); provided, however, that the Parties understand and acknowledge that any such transfer could potentially result in Executive’s ability to resign for Good Reason.

    (g) Exclusive Remedy. 
        Severance benefits provided to the Executive pursuant to this Section 6 are in lieu of, and not in addition to, any benefits to which Executive may otherwise be entitled under any Company severance plan, policy, or program.

    7. Conditions to Receipt of Severance. 
        Any severance payments, equity acceleration, or other payments or benefits under Section 6(a) and (b) above are conditioned on Executive’s not materially breaching the
          Proprietary Rights Agreement (defined below), including the restrictive covenants therein, in a manner that would be reasonably likely to result in a material injury or effect on the Company’s business, operations, prospects or reputation
        as determined by Executive’s Manager in his Manager’s sole reasonable discretion, and on Executive’s signing and not revoking a separation agreement and release, including
          a general release of claims against the Company and certain related persons and entities, in a form reasonably satisfactory to the Company (the “Release”) and such Release becoming effective in accordance with its terms (such date, the “Release
          Effective Date”) within sixty (60) days following Executive’s termination date (the “Release Deadline”), which both Parties agree to take all reasonable steps to accomplish.  Severance payments or benefits shall be paid or commence, as
          applicable, upon the first payroll date following the Release Effective Date and such payment will include the amount of any installment that would otherwise been paid prior to such payment date.  All other benefits, if any, due to Executive
          following a termination will be determined in accordance with the plans, policies and practices of the Company as then in effect.  Notwithstanding the foregoing, to the extent required to comply with Section 409A of the Internal Revenue Code and
          the regulations and guidance promulgated thereunder (“Section 409A”), if the sixty (60) day Release period spans two (2) calendar years, the severance payments will be delayed to the first scheduled payroll date in the second year (and will
          include all payments that would otherwise have been made prior to such date). Severance payments will not be paid or provided until the Release becomes effective and irrevocable.

    
      3

      
        

    

    
    8. Section 409A.  The Parties intend that
        this Agreement be interpreted to comply with or be exempt from Section 409A so that none of the severance payments or benefits provided hereunder will be subject to the
          additional tax imposed under Section 409A. For purposes of determining severance, a termination of employment shall mean not be deemed to have occurred unless the termination is also a “separation from service” within the meaning of Section 409A.
          If Executive is a “specified employee” within the meaning of Section 409A, then the severance and any other separation benefits payable upon a separation from service (whether under this Agreement or otherwise) that would constitute deferred
          compensation under Section 409A (the “Deferred Payments”), otherwise due to Executive on or within the six (6)-month period following Executive’s separation from service will accrue during such six (6)-month period and will become payable in a
          lump sum payment on the date six (6) months and one (1) day following the date of Executive’s separation from service (such rule, the “Six Month Delay Rule”) or, if earlier, the date of Executive’s death. All subsequent Deferred Payments
          following the application of the Six Month Delay Rule, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit or, if earlier, upon the date of Executive’s death. Each payment and benefit payable
          under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to
          take such reasonable actions that are necessary, appropriate or desirable to avoid subjecting Executive to an additional tax or income recognition under Section 409A prior to actual payment of any payments and benefits under this Agreement, as
          applicable. In no event will the Company reimburse Executive for any taxes that may be imposed on Executive as a result of Section 409A.

    9. Limitation on Payments.  In the event
        that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) but for this Section 9, would be subject to the
        excise tax imposed by Section 4999 of the Code, then Executive’s severance benefits under Section 6 will be either:

    (a) delivered in full, or

    (b) delivered as to such lesser extent which would result in no portion of such severance benefits being subject to
        excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state, and local income taxes and the excise tax imposed by Section 4999 of the Code, results in the receipt by Executive on
        an after-tax basis, of the greatest amount of severance benefits, notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code.  If a reduction in severance and other benefits constituting
        “parachute payments” is necessary so that benefits are delivered to a lesser extent, reduction will occur in the following order: (i) reduction of cash payments; (ii) cancellation of awards granted “contingent on a change in ownership or control”
        (within the meaning of Code Section 280G); (iii) cancellation of accelerated vesting of equity awards; or (iv) reduction of employee benefits. In the event that acceleration of vesting of equity award compensation is to be reduced, such
        acceleration of vesting will be cancelled in the reverse order of the date of grant of Executive’s equity awards.  Unless the Company and Executive otherwise agree in writing, any determination required under this Section 9 will be made in writing
        by a nationally recognized accounting or valuation firm (the “Firm”) selected by the Company, whose determination will be conclusive and binding upon Executive and the Company for all purposes.  For purposes of making the calculations required by
        this Section 9, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  The Company and
        Executive will furnish to the Firm such information and documents as the Accountants may reasonably request in order to make a determination under this Section.  The Company will bear all costs the Firm may reasonably incur in connection with any
        calculations contemplated by this Section 9.

    
      4

      
        

    

    10. Definitions.  The
        following terms referred to in this Agreement will have the following meanings:

    (a) Affiliate.  “Affiliate”
        means Company and any other parent or subsidiary corporations of the Company, as such terms are defined in Section 424(e) of the Code.

    (b) Cause.  “Cause” means the
        occurrence of one or more of the following: (i) Executive’s indictment for the commission of any felony or a misdemeanor involving deceit, material dishonesty or fraud, or any other such conduct by Executive that would reasonably be expected to
        result in material injury or reputational harm to the Company if Executive were retained in his position; (ii) Executive’s material violation of this Agreement, the Proprietary Rights Agreement, or any other material agreement with the Company,
        including any misappropriation or disclosure of confidential and proprietary information or trade secrets of the Company and its subsidiaries or affiliates; (iii) continued failure to substantially perform Executive’s duties with the Company (other
        than any such failure resulting from Executive’s Disability) after a written demand for substantial performance is delivered to Executive by his Manager, which is not substantially corrected by Executive to the reasonable satisfaction of his
        Manager within thirty (30) days of receipt of such demand; (iv) a breach by Executive of Executive’s fiduciary duties and responsibilities to the Company that would be reasonably likely to result in a material injury or effect on the Company’s
        business, operations, prospects or reputation; (v)  Executive’s participation in releasing financial statements known by Executive to be false or materially misleading or intentional submission of a false certification to the Securities and
        Exchange Commission or other governmental agency or authority;  (vi) a material violation of the Company’s Code of Ethics or other policies of the Company, that would be reasonably likely to result in a material injury or effect on the Company’s
        business, operations, prospects or reputation as determined by Executive’s Manager in his Manager’s sole reasonable discretion; or (vii)  failure to reasonably cooperate with a bona fide internal investigation or an investigation by regulatory or
        law enforcement authorities, after being instructed by his Manager to cooperate, or the destruction or failure to preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or
        to produce documents or other materials in connection with such investigation.

    (c) Change in Control. 
        “Change in Control” means (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the
        Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s
        assets; (iii) a change in the effective control of the Company which occurs on the date that a majority of the members of the Board of Directors (“Board”) is replaced during any twelve (12) month period by directors whose appointment or election is
        not endorsed by a majority of the members of the Board prior to the date of the appointment or election; or (iv) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which
        would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty
        percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.  Notwithstanding the foregoing definition, any payment or
        benefit that would be considered deferred compensation subject to, and not exempt from, Section 409A, payable or to be provided upon a Change in Control shall only be paid or provided to Executive to the extent such event also qualifies as an event
        described in Internal Revenue Code Section 409A(a)(2)(A)(v).

    (d) Disability.  “Disability” means
          Executive’s entitlement to benefits under Company’s long-term disability plan or if Executive does not participate in Company’s long term-disability plan, Executive’s inability, due to physical or mental incapacity, to perform Executive’s duties
          under this letter Agreement for a period of ninety (90) consecutive days or one-hundred twenty (120) days during any consecutive six (6)-month period.

    
      5

      
        

    

    
    (e) Good Reason.  “Good
        Reason” means Executive’s resignation within thirty (30) days following the expiration of any Company cure period (discussed below) following the occurrence of one or more of the following, without Executive’s written consent: (i) a material
        diminution of Executive’s authority relative to Executive’s authority in effect immediately prior to such diminution; provided, however, that a reduction in the Executive’s authority, duties, or responsibilities solely by virtue of the Company
        being acquired and made part of a larger entity does not constitute “Good Reason” (for example, “Good Reason” does not exist if the Executive is employed by the Company with substantially the same responsibilities with respect to the Company’s
        business that Executive had immediately prior to the Change in Control regardless of whether Executive’s title is revised to reflect Executive’s placement within the overall corporate hierarchy or whether Executive provides services to a
        subsidiary, affiliate, business unit or otherwise); or (ii) a material reduction by the Company in the base compensation or target bonus of the Executive as in effect immediately prior to such reduction, other than a reduction of up to 25% that is
        also applied to other senior executives of the Company such that Executive is not the only senior executive whose base compensation or target bonus is being reduced.  Executive’s resignation will not be deemed to be for Good Reason unless Executive has first provided the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within ninety (90) days of the initial
          existence of the grounds for “Good Reason” and a reasonable cure period of not less than thirty (30) days following the date the Company receives such notice,
          and such condition has not been cured during such period.

    11. Company Matters.

    (a) Proprietary Information and
            Inventions.  Executive acknowledges and agrees that as a condition of his continued employment with the Company under this Agreement, he will be required to sign and comply with an At-Will Employment, Confidential Information,
        Invention Assignment, and Arbitration Agreement (the “Proprietary Rights Agreement”), a copy of which is attached hereto as Exhibit A.  Executive further acknowledges and agrees that he will continue to
          abide by the Company Values and Guidelines and the Company Code of Ethics, which remain in full force and effect, as well as other Company policies as in effect from time to time.  In the event of any conflict between any pre-existing
          confidentiality, non-compete, or non-disclosure obligations and the terms of the restrictive covenants agreement set forth in the Proprietary Rights Agreement, the terms of the Proprietary Rights Agreement shall control.

    (b)  Resignation on Termination. 
        On termination of his employment, regardless of the reason thereof, Executive shall immediately (and with contemporaneous effect) resign any directorships, offices, or other positions he may hold in the Company unless otherwise agreed in writing by
        the Parties.

    (c) Notification of New Employer. 
        In the event that Executive leaves the employ of the Company, Executive grants consent to notification by the Company to Executive’s new employer about his rights and obligations under this Agreement and the Proprietary Rights Agreement.

    12. Arbitration.  IN
        CONSIDERATION OF EXECUTIVE’S CONTINUED EMPLOYMENT WITH THE COMPANY, ITS PROMISE TO ARBITRATE ALL EMPLOYMENT-RELATED DISPUTES AND EXECUTIVE’S RECEIPT OF THE COMPENSATION, PAY RAISES, AND OTHER BENEFITS PAID TO EXECUTIVE BY THE COMPANY, AT PRESENT
        AND IN THE FUTURE, EXECUTIVE AGREES THAT ANY AND ALL CONTROVERSIES, CLAIMS, OR DISPUTES WITH ANYONE (INCLUDING THE COMPANY AND ANY EMPLOYEE, OFFICER, DIRECTOR, SHAREHOLDER, OR BENEFIT PLAN, IN THEIR CAPACITY AS SUCH OR OTHERWISE) ARISING OUT OF,
        RELATING TO, OR RESULTING FROM EXECUTIVE’S EMPLOYMENT WITH THE COMPANY OR THE TERMINATION OF EXECUTIVE’S EMPLOYMENT WITH THE COMPANY, INCLUDING ANY DISPUTES RELATED TO OR ARISING OUT OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION AS SET
        FORTH IN THE PROPRIETARY RIGHTS AGREEMENT, AND SUBJECT TO THE PROVISIONS THEREIN REGARDING PROTECTED ACTIVITY.

    13. Assignment.  This
        Agreement will be binding upon and inure to the benefit of (a) the heirs, executors and legal representatives of Executive upon Executive’s death and (b) any successor of the Company.  Any such successor of the Company will be deemed substituted
        for the Company under the terms of this Agreement for all purposes.  For this purpose, “successor” means any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly
        acquires all or substantially all of the assets or business of the Company.  None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent
        and distribution.  Any other attempted assignment, transfer, conveyance, or other disposition of Executive’s right to compensation or other benefits will be null and void.

    
      6

      
        

    

    14. Notices.  All notices, requests, demands, and other communications called for under this Agreement shall be in writing and shall be delivered personally by hand or by courier, mailed by
          United States first-class mail, postage prepaid, or sent by email directed to the Party to be notified at the physical address or email address indicated for such Party on the signature page to this Agreement, or at such other address or email
          address as such Party may designate by ten (10) days’ advance written notice to the other Party hereto.  All such notices and other communications shall be deemed given upon personal delivery, three (3) days after the date of mailing, or upon
          sending the email.

    15. Severability.  In the
        event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision.

    16. Integration.  This
        Agreement, together with the Proprietary Rights Agreement, any other agreements relating to proprietary rights between you and the Company, the Equity Award Agreements, the Indemnification Agreement, dated August 25, 2020, and the Company’s
        Employee Handbook and Code of Ethics, set forth the terms of Executive’s employment with the Company as of the Effective Date and supersede any prior representations and agreements, whether written or oral.  This Agreement supersedes any prior
        employment agreement between you and the Company, if any.

    17. Tax Withholding.  All
        payments made pursuant to this Agreement will be subject to withholding of applicable taxes.

    18. Waiver.  No Party to this Agreement shall be deemed to have waived any right, power, or privilege under this Agreement or any provisions hereof unless such waiver shall have been duly
          executed in writing and acknowledged by the Party to be charged with such waiver.  No waiver of any breach of this Agreement shall be held to be a waiver of any other subsequent breach.

    19. Governing Law.  This
        Agreement will be governed by the laws of the State of Texas (with the exception of its conflicts of law provisions). Subject to the arbitration provisions referenced above and without limiting such provisions, the Parties agree to exclusive venue
        in the state and federal courts in Austin, Texas.

    20. Acknowledgment. 
        Executive acknowledges that he has had the opportunity to discuss this matter with and obtain advice from his legal counsel, has had sufficient time to, and has carefully read and fully understands all the provisions of this Agreement, and is
        knowingly and voluntarily entering into this Agreement.

    21. Counterparts.  This Agreement may be executed in multiple counterparts, each of which shall be deemed to be an original, and all such counterparts shall constitute but one instrument.

    22. Effect of Headings.  The section and subsection headings contained herein are for convenience only and shall not affect the construction hereof.

    [Signature Page
        Follows]

    
      7

      
        

    

    IN WITNESS
        WHEREOF, the Company and Executive have executed this Agreement as of the day and year first above written.

    

    

    “COMPANY”

    NATIONAL INSTRUMENTS CORPORATION

    

    

    

    

    By:  /s/ Eric Starkloff 

         Eric Starkloff

         President & Chief Executive Officer

    

    

    Address:

    

    

    National Instruments Corporation

    11500 N Mopac Expwy

      Austin, TX 78759-3504

    Attn: General Counsel

    “EXECUTIVE”

    

    

    /s/ Jason Green 

    Jason Green

    

    

    Address:

    3001 Welton Cliff Drive

    Cedar Park, TX 78613

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    NATIONAL INSTRUMENTS CORPORATION

    EXECUTIVE EMPLOYMENT AGREEMENT

    SIGNATURE PAGE

    
      8

      
        

    

    Exhibit A

    

    

    (Proprietary Rights Agreement)

    
      9

      
        

    

    

    

    AT-WILL EMPLOYMENT, CONFIDENTIAL INFORMATION,

    INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT

    As a condition of my employment with National Instruments Corporation (the “Company”), and in consideration of my employment with the Company and my receipt of the compensation paid to me by the Company, I agree to the
      following provisions of this At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (this “Agreement”):

    1. At-Will Employment. I UNDERSTAND AND ACKNOWLEDGE THAT MY EMPLOYMENT
        WITH THE COMPANY IS FOR NO SPECIFIED TERM AND CONSTITUTES “AT-WILL” EMPLOYMENT. I ALSO UNDERSTAND THAT ANY REPRESENTATION TO THE CONTRARY IS NOT VALID UNLESS IN WRITING AND SIGNED BY THE CEO OF THE COMPANY. I ACKNOWLEDGE THAT MY EMPLOYMENT MAY BE
        TERMINATED AT ANY TIME, WITH OR WITHOUT GOOD CAUSE OR FOR ANY OR NO CAUSE, AT MY OPTION OR AT THE OPTION OF THE COMPANY, WITH OR WITHOUT NOTICE.

    2. Confidentiality.

    A. Definition of Company
          Confidential Information. “Company Confidential Information” means information that the Company has or will develop, acquire, create,
        compile, discover or own, that has value in or to the Company’s business that is not generally known and which the Company wishes to maintain as confidential. Company Confidential Information includes both information disclosed by the Company to
        me, and information developed or learned by me during my employment with the Company. Company Confidential Information also includes all information of which the unauthorized disclosure could be detrimental to the interests of the Company, whether
        or not such information is identified as Company Confidential Information. By way of example, and without limitation, Company Confidential Information includes any and all non-public information that relates to the actual or anticipated business
        and/or products, research or development of the Company, or to the Company’s technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company’s products or services and
        markets therefor, customer lists and customers (including, but not limited to, customers of the Company with which I may become acquainted during the term of my employment), software, developments, inventions, discoveries, ideas, processes,
        formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company either directly or indirectly in writing, orally, or by drawings or inspection of
        premises, parts, equipment, or other Company property. Notwithstanding the foregoing, Company Confidential Information shall not include any such information that I can establish (i) was publicly known or made generally available prior to the time
        of disclosure by the Company to me; (ii) becomes publicly known or made generally available after disclosure by the Company to me through no wrongful action or omission by me; or (iii) is in my rightful possession, without confidentiality
        obligations, at the time of disclosure by the Company as shown by my then-contemporaneous written records; provided that any combination of individual items of information shall not be deemed to be within any of the foregoing exceptions merely
        because one or more of the individual items are within such exception, unless the combination as a whole is within such exception.

    B. Nonuse and Nondisclosure.
        During and after my employment with the Company, I will hold in the strictest confidence and take all reasonable precautions to prevent any unauthorized use or disclosure of Company Confidential Information. I will not (i) use Company Confidential
        Information for any purpose whatsoever other than for the benefit of the Company in the course of my employment, or (ii) disclose Company Confidential Information to any third party without the prior written authorization of the CEO of the Company.
        Prior to disclosure, when compelled by applicable law, I shall provide prior written notice to the CEO and General Counsel of the Company (as
        applicable). I agree that I obtain no title to any Company Confidential Information, and that the Company retains all Confidential Information as the sole property of the Company. I understand that my unauthorized use or disclosure of Company
        Confidential Information during my employment may lead to disciplinary action, up to and including, termination and legal action by the Company. I understand that my obligations under this section shall continue after termination of my employment
        and that nothing in this Agreement prevents me from engaging in protected activity, as described below.

    
      10

      
        

    

    C. Former Employer Confidential
          Information. I agree that during my employment with the Company, I will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former employer or other person or entity with which I
        have an obligation to keep such proprietary information or trade secrets in confidence. I further agree that I will not bring onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary
        information, or trade secrets belonging to any such third party unless disclosure to, and use by, the Company has been consented to, in writing, by such third party and the Company.

    D. Third Party Information.
        I recognize that the Company has received, and in the future may receive, from third parties (for example, customers, suppliers, licensors, licensees, partners, and collaborators) as well as its subsidiaries and affiliates (“Associated Third Parties”), information that the Company is required to maintain and treat as confidential or proprietary information of such Associated Third Parties
        (“Associated Third Party Confidential Information”), and I agree to use such Associated Third Party Confidential Information only as directed by
        the Company and to not use or disclose such Associated Third Party Confidential Information in a manner that would violate the Company’s obligations to such Associated Third Parties. I agree at all times during my employment with the Company and
        thereafter, that I owe the Company and its Associated Third Parties a duty to hold all such Associated Third Party Confidential Information in the strictest confidence, and not to use it or to disclose it to any person, firm, corporation, or other
        third party except as necessary in carrying out my work for the Company consistent with the Company’s agreement with such Associated Third Parties.

    3. Ownership.

    A. Assignment of Inventions.
        As between the Company and myself, I agree that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings, designs, logos, inventions, improvements, developments, discoveries, ideas and trade secrets
        conceived, discovered, authored, invented, developed, or reduced to practice by me, solely or in collaboration with others, during the period of time I am in the employ of the Company (including during my off-duty hours), or with the use of the
        Company’s equipment, supplies, facilities, or Company Confidential Information, and any copyrights, patents, trade secrets, mask work rights or other intellectual property rights relating to the foregoing, except as provided in Section 3.F below (collectively, “Inventions”), are the
        sole property of the Company. I also agree to promptly make full written disclosure to the Company of any Inventions, and to deliver and assign and hereby irrevocably assign fully to the Company all of my right, title and interest in and to
        Inventions. I agree that this assignment includes a present conveyance to the Company of ownership of Inventions that are not yet in existence. I further acknowledge that all original works of authorship that are made by me (solely or jointly with
        others) within the scope of and during the period of my employment with the Company and that are protectable by copyright are “works made for hire,” as that term is defined in the United States Copyright Act. I understand and agree that the
        decision whether or not to commercialize or market any Inventions is within the Company’s sole discretion and for the Company’s sole benefit, and that no royalty or other consideration will be due to me as a result of the Company’s efforts to
        commercialize or market any such Inventions.

    B. Pre-Existing Materials.
        I will inform the Company, in writing, before incorporating any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets and other proprietary information or intellectual property rights owned by me or
        in which I have an interest prior to, or separate from, my employment with the Company, including, without limitation, any such inventions that qualify as an “Other Invention” as defined below in Section 3.F (“Prior Inventions”) into any Invention or otherwise utilizing any Prior Invention in the course of my employment with the Company; and the Company is hereby granted a
        nonexclusive, royalty-free, perpetual, irrevocable, transferable worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import,
          offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such incorporated or utilized Prior Inventions, without restriction, including, without limitation, as part of, or in
          connection with, such Invention, and to practice any method related thereto. I will not incorporate any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets and other proprietary
        information or intellectual property rights owned by any third party into any Invention without the Company’s prior written permission. I have attached hereto, as Exhibit

            A, a list describing all Prior Inventions that relate to the Company’s current or anticipated business, products, or research and development or, if no such list is attached, I represent and warrant that there are no such Prior
        Inventions. Furthermore, I represent and warrant that if any Prior Inventions are included on Exhibit A, they will not materially affect my ability to
        perform all obligations under this Agreement.

    
      10

      
        

    

    
    C. Moral Rights. Any
        assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,” “artist’s
        rights,” “droit moral,” or the like (collectively, “Moral Rights”). To the extent that Moral Rights cannot be assigned under applicable law, I
        hereby waive and agree not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law.

    D. Further Assurances. I
        agree to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions in any and all countries, including the disclosure to the Company of all pertinent information and data
        with respect thereto, the execution of all applications, specifications, oaths, assignments, and all other instruments that the Company shall deem proper or necessary in order to apply for, register, obtain, maintain, defend, and enforce such
        rights, and in order to deliver, assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title, and interest in and to all Inventions, and testifying in a suit or other proceeding relating to such
        Inventions. I further agree that my obligations under this Section 3.D shall continue after the termination of this Agreement.

    E. Attorney-in-Fact. I
        agree that, if the Company is unable because of my unavailability, mental or physical incapacity, or for any other reason to secure my signature with respect to any Inventions, including, without limitation, for the purpose of applying for or
        pursuing any application for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.A, then I hereby irrevocably designate and appoint the Company and its duly
        authorized officers and agents as my agent and attorney-in-fact, to act for and on my behalf to execute and file any papers and oaths, and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and
        issuance of patents, copyright and mask work registrations with the same legal force and effect as if executed by me. This power of attorney shall be deemed coupled with an interest and shall be irrevocable.

    F. Exception

          to Assignments. I UNDERSTAND THAT THE PROVISIONS OF THIS AGREEMENT REQUIRING ASSIGNMENT OF INVENTIONS (AS DEFINED UNDER SECTION 3.A ABOVE) TO THE COMPANY DO NOT APPLY TO ANY INVENTION FOR WHICH NO EQUIPMENT SUPPLIES, FACILITY, OR TRADE
        SECRET INFORMATION OF THE COMPANY WAS USED AND WHICH WAS DEVELOPED ENTIRELY ON MY OWN TIME (AN “OTHER INVENTION”) EXCEPT FOR THOSE OTHER
        INVENTIONS THAT RELATE: (A) DIRECTLY TO THE BUSINESS OF THE COMPANY; (B) TO THE COMPANY’S ACTUAL OR DEMONSTRABLY ANTICIPATED RESEARCH OR DEVELOPMENT; OR (C) RESULT FROM ANY WORK I PERFORM FOR THE COMPANY. I WILL NOT INCORPORATE, OR PERMIT TO BE
        INCORPORATED, ANY OTHER INVENTION OWNED BY ME OR IN WHICH I HAVE AN INTEREST INTO A COMPANY PRODUCT, PROCESS OR SERVICE WITHOUT THE COMPANY’S PRIOR WRITTEN CONSENT. I WILL ADVISE THE COMPANY PROMPTLY IN WRITING OF ANY INVENTIONS THAT I BELIEVE MEET
        THE ABOVE CRITERIA AND ARE NOT OTHERWISE DISCLOSED ON EXHIBIT A TO PERMIT A DETERMINATION OF OWNERSHIP BY THE COMPANY. ANY SUCH DISCLOSURE WILL BE RECEIVED
        IN CONFIDENCE.

    4. Conflicting Obligations. I agree that during my employment with the Company, I will not engage in any other employment,
          occupation, consulting relationship, or commitment that is directly related to the business in which the Company is now involved or becomes involved or has plans to become involved, nor will I engage in any other activities that conflict with my
          obligations to the Company. I represent and warrant that I have no other agreements, relationships, or commitments to any other person or entity that conflict with the provisions of this Agreement or my ability to be employed and perform services
          for the Company. I further agree that if I have signed a confidentiality agreement or similar type of agreement with any former employer or other entity, I will comply with the terms of any such agreement to the extent that its terms are lawful
          under applicable law, as advised by counsel to the extent such advice is deemed necessary. I represent and warrant that after undertaking a careful search, I
          have returned all property and confidential information belonging to all prior employers (and/or other third parties I have performed services for in accordance with the terms of any such applicable agreements).

    
      12

      
        

    

    5. Notification

            of New Employer. If I leave the employ of the Company, I hereby grant consent to notification by the Company to my new employer about my obligations under this Agreement.

    6. Company

            Policies. I agree to adhere to all policies of the Company, including, but not limited to, the Company’s insider trading and conflict of interest policies
          as well as policies governing use of the Company’s documents and the Company’s internet, email, telephone, and technology systems to which I will have access during my employment.

    7. Covenant Not to Compete and No Solicitation.

    A. Covenant Not to Compete. 
        I agree that during the course of my employment and for a period of twelve (12) months immediately following the termination of my relationship with the Company for any reason, whether with or without cause, at the option either of the Company or
        myself, with or without notice, I will not, without the prior written consent of the Company: (i) serve as a partner, principal, licensor, licensee, employee, consultant, officer, director, manager, agent, affiliate, representative, advisor,
        promoter, associate, investor, or otherwise for (except for passive ownership of one percent (1%) or less of any entity whose securities have been registered under the Securities Act of 1933, as amended, or Section 12 of the Securities Exchange Act
        of 1934, as amended); (ii) directly or indirectly, own, purchase, organize or take preparatory steps for the organization of; or (iii) build, design, finance, acquire, lease, operate, manage, control, invest in, work or consult for or otherwise
        join, participate in or affiliate myself with, any business whose business, products or operations are in any respect involved in the Covered Business.  For purposes of this Agreement, “Covered Business” shall mean any business in which the Company is engaged or in which the Company has plans to be engaged, or any service that the Company provides or has plans to provide.  The foregoing
        covenant shall cover my activities in every part of the Territory.  For purposes of this Agreement, “Territory” shall mean: (i) all counties in
        the State of Texas; (ii) all other states of the United States of America in which the Company provided goods or services, had customers, or otherwise conducted business at any time during the two-year period prior to the date of the termination of
        my relationship with the Company; and (iii) any other countries from which the Company maintains non-trivial operations or facilities, provided goods or services, had customers, or otherwise conducted business at any time during the two-year period
        prior to the date of the termination of my relationship with the Company.  Should I obtain other employment during my employment with the Company or within twelve (12) months immediately following the termination of my relationship with the
        Company, I agree to provide written notification to the Company as to the name and address of my new employer, the position that I expect to hold, and a general description of my duties and responsibilities, at least three (3) business days prior
        to starting such employment.

    B. No Solicitation.

    (1) Non-Solicitation of
          Customers.  I agree that for a period of twelve (12) months immediately following the termination of my relationship with the Company for any reason, whether with or without cause, at the option either of the Company or myself, with or
        without notice, I will not contact, or cause to be contacted, directly or indirectly, or engage in any form of oral, verbal, written, recorded, transcribed, or electronic communication with any Customer for the purposes of conducting business that
        is competitive or similar to that of the Company or for the purpose of disadvantaging the Company’s business in any way.  For purposes of this Agreement, “Customer” shall mean all persons or entities that have used or inquired of the Company’s services at any time during the two-year period preceding the termination of my employment with the Company.  I acknowledge and agree that the
        Customers did not use or inquire of the Company’s services solely as a result of my efforts, and that the efforts of other Company personnel and resources are responsible for the Company’s relationship with the Customers.  I further acknowledge and
        agree that the identity of the Customers is not readily ascertainable or discoverable through public sources, and that the Company’s list of Customers was cultivated with great effort and secured through the expenditure of considerable time and
        money by the Company.

    (2) Non-Solicitation of
          Employees.  I agree that for a period of twelve (12) months immediately following the termination of my relationship with the Company for any reason, whether with or without cause, at the option either of the Company or myself, with or
        without notice, I will not directly or indirectly hire, solicit, or recruit, or attempt to hire, solicit, or recruit, any employee of the Company to leave their employment with the Company, nor will I contact any employee of the Company, or cause
        an employee of the Company to be contacted, for the purpose of leaving employment with the Company.

    
      13

      
        

    

    
    (3) Non-Solicitation of
          Others.  I agree that for a period of twelve (12) months immediately following the termination of my relationship with the Company for any reason, whether with or without cause, at the option either of the Company or myself, with or
        without notice, I will not solicit, encourage, or induce, or cause to be solicited, encouraged or induced, directly or indirectly, any franchisee, joint venture, supplier, vendor or contractor who conducted business with the Company at any time
        during the two-year period preceding the termination of my employment with the Company, to terminate or adversely modify any business relationship with the Company or not to proceed with, or enter into, any business relationship with the Company,
        nor shall I otherwise interfere with any business relationship between the Company and any such franchisee, joint venture, supplier, vendor or contractor.

    C. Acknowledgements. 
        I acknowledge that I will derive significant value from the Company’s agreement to provide me with Company Confidential Information to enable me to optimize the performance of my duties to the Company.  I further acknowledge that my fulfillment of
        the obligations contained in this Agreement, including, but not limited to, my obligation neither to disclose nor to use Company Confidential Information other than for the Company’s exclusive benefit and my obligations not to compete and not to
        solicit contained in subsections (A) and (B) above, is necessary to protect Company Confidential Information and, consequently, to preserve the value and goodwill of the Company.  I also acknowledge the time, geographic and scope limitations of my
        obligations under subsections (A) and (B) above are fair and reasonable in all respects, especially in light of the Company’s need to protect Company Confidential Information and the scope and nature of the Company’s business, and that I will not
        be precluded from gainful employment if I am obligated not to compete with the Company or solicit its customers, employees, or others during the period and within the Territory as described above.  In the event of my breach or violation of this
        Section 8, or good faith allegation by the Company of my breach or violation of this Section 8, the restricted periods set forth in this Section 8 shall be tolled until such breach or violation, or dispute related to an allegation by the Company
        that I have breached or violated this Section 8, has been duly cured or resolved, as applicable.  I agree that nothing in this Section 8 shall affect my continuing obligations under this Agreement during and after this twelve (12) month period,
        including, without limitation, my obligations under Section 2.

    D. Separate

          Covenants.  The covenants contained in subsections (A) and (B) above shall be construed as a series of separate covenants, one for each city, county and state of any geographic area in the Territory.  Except for geographic coverage, each
        such separate covenant shall be deemed identical in terms to the covenant contained in subsections (A) and (B) above.  If, in any judicial or arbitral proceeding, a court or arbitrator refuses to enforce any of such separate covenants (or any part
        thereof), then such unenforceable covenant (or such part) shall be revised, or if revision is not permitted it shall be eliminated from this Agreement, to the extent necessary to permit the remaining separate covenants (or portions thereof) to be
        enforced.  In the event that the provisions of subsections (A) and (B) above are deemed to exceed the time, geographic or scope limitations permitted by applicable law, then such provisions shall be reformed to the maximum time, geographic or scope
        limitations, as the case may be, then permitted by such law.  In the event that the applicable court or arbitrator does not exercise the power granted to it in the prior sentence, I and the Company agree to replace such invalid or unenforceable
        term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term.

    8. Representations. Without limiting my obligations under Section 3.D above, I agree to execute any proper oath or verify any proper document required to carry out the terms of this Agreement. I represent
        and warrant that my performance of the terms of this Agreement will not breach any agreement to keep confidential information acquired by me in confidence or in trust prior to my employment by the Company. I hereby represent and warrant that I have
        not entered into, and I will not enter into, any oral or written agreement in conflict herewith.

    
      14

      
        

    

    9. Arbitration and Equitable Relief.

    A. Arbitration.
        IN CONSIDERATION OF MY EMPLOYMENT WITH THE COMPANY, ITS PROMISE TO ARBITRATE ALL EMPLOYMENT-RELATED DISPUTES WITH ME, AND MY RECEIPT OF COMPENSATION, AND OTHER COMPANY BENEFITS, AT PRESENT AND IN THE FUTURE, I AGREE THAT ANY AND ALL CONTROVERSIES,
        CLAIMS, OR DISPUTES THAT I MAY HAVE WITH THE COMPANY (INCLUDING ANY COMPANY EMPLOYEE, OFFICER, DIRECTOR, TRUSTEE, OR BENEFIT PLAN OF THE COMPANY, IN THEIR CAPACITY AS SUCH OR OTHERWISE), ARISING OUT OF, RELATING TO, OR RESULTING FROM MY EMPLOYMENT
        WITH THE COMPANY OR THE TERMINATION OF MY EMPLOYMENT WITH THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION PURSUANT TO THE FEDERAL ARBITRATION ACT (9 U.S.C. SEC. 1 ET SEQ.) (THE “FAA”).  THE FAA’S
        SUBSTANTIVE AND PROCEDURAL PROVISIONS SHALL EXCLUSIVELY GOVERN AND APPLY WITH FULL FORCE AND EFFECT TO THIS ARBITRATION AGREEMENT, INCLUDING ITS ENFORCEMENT, AND ANY STATE COURT OF COMPETENT JURISDICTION SHALL COMPEL ARBITRATION IN THE SAME MANNER
        AS A FEDERAL COURT UNDER THE FAA.  I FURTHER AGREE THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, I MAY BRING ANY ARBITRATION PROCEEDING ONLY IN MY INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF, REPRESENTATIVE OR CLASS MEMBER IN ANY PURPORTED CLASS,
        COLLECTIVE OR REPRESENTATIVE LAWSUIT OR PROCEEDING. TO THE FULLEST EXTENT PERMITTED BY LAW, I AGREE TO ARBITRATE ANY AND ALL COMMON LAW AND/OR STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW, INCLUDING, BUT NOT LIMITED TO, CLAIMS UNDER TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, THE
          AMERICANS WITH DISABILITIES ACT OF 1990, THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE OLDER WORKERS BENEFIT PROTECTION ACT, THE WORKER ADJUSTMENT AND RETRAINING NOTIFICATION ACT, THE FAIR LABOR STANDARDS ACT, THE FAMILY AND MEDICAL LEAVE
          ACT, THE TEXAS COMMISSION ON HUMAN RIGHTS ACT, CLAIMS RELATING TO EMPLOYMENT STATUS, COMPENSATION, CLASSIFICATION, HARASSMENT, DISCRIMINATION, WRONGFUL TERMINATION, AND BREACH OF CONTRACT. TO THE FULLEST EXTENT PERMITTED BY LAW, I ALSO AGREE TO
          ARBITRATE ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE INTERPRETATION OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT DISPUTES ABOUT THE ENFORCEABILITY, REVOCABILITY, OR VALIDITY OF THIS AGREEMENT TO ARBITRATE OR THE CLASS,
          COLLECTIVE, AND REPRESENTATIVE PROCEEDING WAIVER HEREIN. WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT I AGREE TO ARBITRATE, I HEREBY EXPRESSLY AGREE TO WAIVE, AND DO WAIVE, ANY RIGHT TO A TRIAL BY JURY. I FURTHER UNDERSTAND THAT THIS
        AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH ME.  I UNDERSTAND THAT NOTHING IN THIS AGREEMENT REQUIRES ME TO ARBITRATE CLAIMS THAT CANNOT BE ARBITRATED UNDER THE SARBANES-OXLEY ACT OR OTHER LAW THAT EXPRESSLY
        PROHIBITS ARBITRATION OF A CLAIM NOTWITHSTANDING THE APPLICATION OF THE FAA.

    B. Administration

          of Arbitration. I AGREE THAT ANY ARBITRATION WILL BE ADMINISTERED BY JAMS, PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (THE “JAMS

          RULES”), AVAILABLE AT https://www.jamsadr.com/rules-employment-arbitration/. IF THE JAMS RULES CANNOT BE ENFORCED AS TO THE ARBITRATION, THEN THE PARTIES
        AGREE THAT THEY WILL ARBITRATE THIS DISPUTE UTILIZING JAMS COMPREHENSIVE ARBITRATION RULES AND PROCEDURES OR SUCH RULES AS THE ARBITRATOR MAY DEEM MOST APPROPRIATE FOR THE DISPUTE. I AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY
        MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, APPLYING THE STANDARDS SET FORTH FOR SUCH MOTIONS UNDER THE TEXAS RULES OF CIVIL PROCEDURE. I AGREE THAT THE ARBITRATOR SHALL ISSUE A WRITTEN DECISION ON THE MERITS. I ALSO AGREE THAT THE ARBITRATOR
        SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR MAY AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW. I AGREE THAT THE DECREE OR AWARD RENDERED BY THE
        ARBITRATOR MAY BE ENTERED AS A FINAL AND BINDING JUDGMENT IN ANY COURT HAVING JURISDICTION THEREOF. THE COMPANY AGREES THAT THE COMPANY WILL PAY FOR ANY FEES OR COSTS CHARGED BY JAMS OR THE ARBITRATOR OR COURT REPORTERS, INCLUDING ADMINISTRATIVE OR
        HEARING FEES CHARGED BY THE ARBITRATOR OR JAMS EXCEPT THAT I SHALL PAY ANY FILING FEES ASSOCIATED WITH ANY ARBITRATION THAT I INITIATE, BUT ONLY SO MUCH OF THE FILING FEES AS I WOULD HAVE INSTEAD PAID HAD I FILED A COMPLAINT IN A COURT THAT WOULD
        HAVE HAD JURISDICTION OVER SUCH COMPLAINT. I AGREE THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH TEXAS LAW, INCLUDING THE TEXAS RULES OF CIVIL PROCEDURE AND THE TEXAS RULES OF EVIDENCE, AND THAT THE ARBITRATOR
        SHALL APPLY SUBSTANTIVE AND PROCEDURAL TEXAS LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO RULES OF CONFLICT-OF-LAW. TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH TEXAS LAW, TEXAS LAW SHALL TAKE PRECEDENCE. I AGREE THAT ANY ARBITRATION UNDER
        THIS AGREEMENT SHALL BE CONDUCTED IN TRAVIS COUNTY, TEXAS.

    
      15

      
        

    

    
    C. Remedy.
        EXCEPT AS PROVIDED BY THE FAA OR THIS AGREEMENT, ARBITRATION SHALL BE THE SOLE, EXCLUSIVE, AND FINAL REMEDY FOR ANY DISPUTE BETWEEN ME AND THE COMPANY. ACCORDINGLY, EXCEPT AS PROVIDED FOR BY THE FAA OR THIS AGREEMENT, NEITHER I NOR THE COMPANY WILL
        BE PERMITTED TO PURSUE OR PARTICIPATE IN A COURT ACTION REGARDING CLAIMS THAT ARE SUBJECT TO ARBITRATION.

    D. Administrative

          Relief. I UNDERSTAND THAT THIS AGREEMENT DOES NOT PROHIBIT ME FROM PURSUING AN ADMINISTRATIVE CLAIM WITH AN ADMINISTRATIVE BODY OR GOVERNMENT AGENCY AUTHORIZED TO ENFORCE OR ADMINISTER LAWS RELATED TO EMPLOYMENT. THIS AGREEMENT DOES
        PRECLUDE ME FROM PURSUING A COURT ACTION REGARDING ANY SUCH CLAIM, EXCEPT AS PERMITTED BY LAW.

    E. Voluntary

          Nature of Agreement. I ACKNOWLEDGE AND AGREE THAT I AM EXECUTING THIS AGREEMENT VOLUNTARILY AND WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE. I FURTHER ACKNOWLEDGE AND AGREE THAT I HAVE CAREFULLY READ THIS AGREEMENT
        AND THAT I HAVE ASKED ANY QUESTIONS NEEDED FOR ME TO UNDERSTAND THE TERMS, CONSEQUENCES, AND BINDING EFFECT OF THIS AGREEMENT AND FULLY UNDERSTAND IT, INCLUDING THAT I AM WAIVING MY RIGHT TO A JURY TRIAL. I AGREE THAT I HAVE BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF MY CHOICE BEFORE SIGNING THIS AGREEMENT.

    10. Miscellaneous.

    A. Governing Law; Consent to
          Personal Jurisdiction. This Agreement will be governed by the laws of the State of Texas without regard to Texas’ conflicts-of-law, except that any dispute
          regarding the enforceability of the arbitration section of this Agreement shall be governed by the FAA. To the extent that any lawsuit is permitted under this Agreement, the Company and I hereby expressly consent to the personal and exclusive
          jurisdiction and venue of the state and federal courts located in Travis County, Texas for any lawsuit filed against me by the Company or against the Company by me.

    B. Assignability. This
        Agreement will be binding upon my heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns. The Associated Third Parties are intended third-party
        beneficiaries to this Agreement with respect to my obligations in Section 2.D. Notwithstanding anything to the contrary herein, the Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all, or
        substantially all, of the Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, or otherwise. For the avoidance of doubt, the Company’s successors and assigns are authorized to
        enforce the Company’s rights under this Agreement.

    
      16

      
        

    

    C. Entire Agreement. This
        Agreement, together with the Exhibits herein and any executed written offer letter between me and the Company, to the extent such materials are not in conflict with this Agreement, sets forth the entire agreement and understanding between the
        Company and me with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between us. I represent and warrant that I am not relying on any representation not contained in this
        Agreement. Any subsequent change or changes in my duties, salary, compensation, conditions, or any other terms of my employment will not affect the validity or scope of this Agreement.

    D. Severability. If a
        court or other body of competent jurisdiction finds, or the parties mutually believe, any provision of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to
        effect the intent of the parties, and the remainder of this Agreement will continue in full force and effect.

    E. Modification, Waiver. No

        modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in a writing signed by the CEO of the Company and me. Waiver by the Company of a breach of any provision of this Agreement
        will not operate as a waiver of any other or subsequent breach.

    F. Survivorship. The
        rights and obligations of the parties to this Agreement will survive termination of my employment with the Company.

    11. Protected Activity Not Prohibited. I understand that nothing in this Agreement limits or prohibits me from filing and/or
          pursuing a charge or complaint with, or otherwise communicating or cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state, or local government agency or commission, including disclosing
          documents or other information as permitted by law, without giving notice to, or receiving authorization from, the Company. In addition, nothing in this Agreement, including its definition of Company Confidential Information, is intended to limit
          employees’ rights to discuss the terms, wages, and working conditions of their employment, nor to deny employees the right to disclose information pertaining to sexual harassment or any unlawful or potentially unlawful conduct, as protected by
          applicable law. I further understand that I am not permitted to disclose the Company’s attorney-client privileged communications or attorney work product. In addition, I hereby acknowledge that the Company has provided me with notice in
          compliance with the Defend Trade Secrets Act of 2016 regarding immunity from liability for limited disclosures of trade secrets. The full text of the notice is attached in Exhibit B.

    

    

    

    

    

    

    
      	
              Date: February 19, 2021

            	
              /s/ Jason Green

            	
               

            
	 	
              Signature

            	 
	 	 	 
	 	 	 
	 	
              Jason Green

            	 
	 	
              Name of Employee (typed or printed)

            	 

    

    

    
      17

      
        

    

    EXHIBIT A

    LIST OF PRIOR INVENTIONS

    AND ORIGINAL WORKS OF AUTHORSHIP

    	
            
               

              Title

               

            

          	
            
               

              Applicable Date

               

            

          	
            
               

              Identifying Registration Number or Brief Description

               

            

          
	 	 	 
	 	 	 
	 	 	 
	 	 	 

    _X__ No inventions or
      improvements

    ___ Additional Sheets Attached

    

    

    
      	
              Date: February 19, 2021

            	
              /s/ Jason Green

            	
               

            
	 	
              Signature

            	 
	 	 	 
	 	 	 
	 	
              Jason Green

            	 
	 	
              Name of Employee (typed or printed)

               

            	 

    

    

    
      18

      
        

    

    EXHIBIT B

    SECTION 7 OF THE DEFEND TRADE SECRETS ACT OF 2016

    

    

    “ . . . An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure
      of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or
      (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. . . . An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the
      trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual—(A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant
      to court order.”

  

   

  

  
    19

    
      

  

  
  EXHIBIT B: To the Transition Agreement and Release

    
    

    

  

  SEPARATION AGREEMENT AND RELEASE

  

  

  This Separation Agreement and Release (“Separation Agreement”) is made by and between Jason Green (“Executive”) and
    National Instruments Corporation (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

  

  

  RECITALS

  

  

  WHEREAS, the Parties have entered into a Transition Agreement and Release (the “Transition Agreement”) to which this
    Separation Agreement is attached as Exhibit B, and all terms capitalized but not defined in this Separation Agreement shall have the meanings given to them in
    the Transition Agreement; and

  

  

  WHEREAS, the Parties wish to resolve
      any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Executive may have against the Company and any of the
      Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive’s employment with or separation from
      the Company.

  

  

  NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as
    follows:

  COVENANTS

  

  

  1. Consideration.  In consideration of Executive’s
      execution of this Separation Agreement, and contingent upon Executive’s fulfillment of all of the terms and conditions set forth herein, and provided Executive does not revoke this Separation Agreement under Section 6 below, the Company agrees as
      follows:

  

  

  a. Continued Employment During the Transition Period. 
      The Company has allowed Executive to continue employment with the Company during the Transition Period in consideration for his agreement to sign this Separation Agreement on or after the Separation Date.

  

  

  b. Separation Payment. The Company agrees to
      pay Executive a total of Five Hundred Ninety-Five Thousand Dollars and No Cents ($595,000.00), at the gross rate of Twenty-Two Thousand Eight Hundred Eighty-Four Dollars and Sixty-Two Cents ($22,884.62) per bi-weekly payroll period, less applicable
      withholdings, for twelve (12) months from the first regular payroll date following the Effective Date (as defined below), in accordance with the Company’s regular payroll practices.

  

  

  c. Accelerated Vesting. The Compensation
      Committee of the Company’s Board of Directors having already approved accelerated vesting as provided in this Section 1(c), upon the Effective Date of this Separation Agreement, the Equity Awards that are subject only to service-based vesting will
      vest as to the portion of each applicable Equity Award that would be scheduled to vest if Executive had remained employed through December 31, 2023. For the avoidance of doubt, 22,582 shares of the Company’s common stock are subject to accelerated
      vesting pursuant to this Section 1(c). For the further avoidance of doubt, any Equity Awards subject to performance-based vesting that will vest after the Separation Date will not vest pursuant to this Separation Agreement. This Section 1(c)
      expressly acts as an amendment to the Equity Documents memorializing any Equity Awards.  Other than as amended by this Section 1(c), the Equity Awards will continue to be governed by the terms and conditions of the Equity Documents.

  

  

  d. Supplemental Payment In Lieu of Executive
        Incentive Program Payout. The Company agrees to pay Executive a lump sum total of Five Hundred Ninety-Five Thousand Dollars and No Cents ($595,000.00), less applicable withholdings, which is equivalent to one hundred percent (100%) of
      Executive’s bonus, at an annual target of one hundred percent (100%) of Executive’s base salary, for which Executive would have been eligible under the Executive Incentive Program had he remained employed on the bonus payment date.  This payment will
      be made to Executive at such time the Executive Incentive Program bonus is paid to other senior executives of the Company.

  
    10

    
      

  

  

  

  e. COBRA. The Company shall reimburse
      Executive for, or pay directly on Executive’s behalf, the premiums for healthcare continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) for Executive and Executive’s eligible dependents (as
      applicable) through December 31, 2023, or until Executive has secured health insurance coverage through another employer, whichever occurs first (the “COBRA Continuation Period”), provided Executive timely elects COBRA continuation coverage within
      the time period prescribed pursuant to COBRA. Notwithstanding the preceding, if the Company determines in its sole discretion that it cannot provide COBRA reimbursement benefits without potentially violating applicable law (including, without
      limitation, Section 2716 of the Public Health Service Act), the Company will instead provide the Executive a taxable payment in an amount equal to the monthly COBRA premium that he would be required to pay to continue the Executive’s group health
      coverage in effect on the date of termination of employment (which amount will be based on the premium for the first month of COBRA coverage), which payments will be made regardless of whether Executive elects COBRA continuation coverage and will
      apply to each month remaining in  the COBRA Continuation Period for which such determination has been made.

  

  

  f. Company-Owned Laptop Computer. The Company
      agrees to transfer ownership of the Company-owned laptop computer issued to Executive during his employment to Executive upon the Effective Date of this Separation Agreement; provided, however, that the laptop computer will be wiped and reset by the Company before ownership is transferred to Executive.

  

  

  g. Acknowledgement. Executive acknowledges
      that without this Separation Agreement, Executive is otherwise not entitled to the consideration listed in this Section 1.

  

  

  2. Equity Awards.  The Parties agree that for purposes of
      determining the number of shares of the Company’s common stock that Executive is entitled to receive from the Company, pursuant to the vesting of outstanding Equity Awards, Executive will be considered to have vested only up to the Separation Date; provided, however, that Executive is eligible for acceleration of
      vesting of certain Equity Awards subject to service-based vesting as set forth in Section 1(c) of this Separation Agreement.  All unvested shares subject to outstanding Equity Awards as of the Separation Date will terminate on the Separation Date
      (excluding, for avoidance of doubt, any shares for which vesting is accelerated under Section 1(c) of this Separation Agreement). Other than as set forth in Section 1(c) of this Separation Agreement, the Equity Awards shall continue to be governed by
      the terms and conditions of the Equity Documents.

  

  

  3. Benefits.  Executive’s health insurance benefits shall
      cease on the last day of the month in which he is employed by the Company, subject to his right to continue his health insurance under COBRA. Executive’s participation in all benefits and incidents of employment, including, but not limited to,
      vesting in stock, and the accrual of bonuses, vacation, and paid time off, cease as of the Separation Date.

  

  

  4. Payment of Salary and Receipt of All Benefits. 
      Executive acknowledges and represents that, other than the consideration set forth in this Separation Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, premiums, leaves, housing allowances,
      relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, vesting, and any and all other benefits and compensation that may be due to Executive.

  

  

  5. Release of Claims.  Executive agrees that the foregoing
      consideration represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit
      plans, plan administrators, professional employer organization or co-employer, insurers, trustees, divisions, subsidiaries, predecessor and
      successor corporations, and assigns (collectively, “Releasees”). Executive, on his behalf and on behalf of his respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue
      concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that
      Executive may possess against any Releasee arising from any omissions, acts, facts, or damages occurring up until and including the date Executive signs this Separation Agreement, including, without limitation:

  
    11

    
      

  

  
  a. any and all claims relating to or arising from Executive’s employment relationship with the Company and the termination of that relationship;

  

  

  b. any and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of shares of stock of the Company, including,
      without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

  

  

  c. any and all claims for wrongful discharge of employment, termination in violation of public policy, discrimination, harassment, retaliation, breach
      of contract (both express and implied), breach of covenant of good faith and fair dealing (both express and implied), promissory estoppel, negligent or intentional infliction of emotional distress, fraud, negligent or intentional misrepresentation,
      negligent or intentional interference with contract or prospective economic advantage, unfair business practices, defamation, libel, slander, negligence, personal injury, assault, battery, invasion of privacy, false imprisonment, conversion, and
      disability benefits;

  

  

  d. any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of
      1964, the Civil Rights Act of 1991, the Rehabilitation Act of 1973, the Americans with Disabilities Act of 1990, the Equal Pay Act, the Fair Labor Standards Act, the Fair Credit Reporting Act, the Age Discrimination in Employment Act of 1967, the
      Older Workers Benefit Protection Act, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining Notification Act, the Family and Medical Leave Act, the Immigration Reform and Control Act, the National Labor Relations
      Act, the Texas Payday Act, the Texas Workers’ Compensation Act, and Chapter 21 of the Texas Labor Code (also known as the Texas Commission on Human Rights Act);

  

  

  e. any and all claims for violation of the federal or any state constitution;

  

  

  f. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;

  

  

  g. any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the proceeds
      received by Executive as a result of this Separation Agreement; and

  

  

  h. any and all claims for attorneys’ fees and costs.

  

  

  Executive agrees that the release set forth in this Section shall be and remain in effect in all respects as a complete general release
    as to the matters released. Notwithstanding anything to the contrary herein, this Separation Agreement does not waive or release any rights or claims Executive may have to indemnification, defense, advancement, or insurance coverage under the
    Indemnification Agreement or any law, regulation, bylaw, article of incorporation, or insurance policy. This release does not extend to any obligations incurred under this Separation Agreement. This release does not release claims that cannot be
    released as a matter of law. Any disputed wage claims that are released herein shall be subject to binding arbitration in accordance with this Separation Agreement, except as required by applicable law. This release does not extend to any right
    Executive may have to unemployment compensation benefits.

  
    12

    
      

  

  6. Acknowledgment of Waiver of Claims under ADEA. Executive
      acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary.  Executive agrees that this waiver and release does not
      apply to any rights or claims that may arise under the ADEA after the Effective Date of this Separation Agreement.  Executive acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive
      was already entitled.  Executive further acknowledges that he has been advised by this writing that: (a) he should consult with an attorney prior to executing
      this Separation Agreement; (b) he has twenty-one (21) days within which to consider this Separation Agreement; (c) he has seven (7) days following his execution of this Separation Agreement to revoke this Separation Agreement; (d) this Separation
      Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Separation Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver
      under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law.  In the event Executive signs this Separation Agreement and returns it to the Company in less than the 21-day
      period identified above, Executive hereby acknowledges that he has freely and voluntarily chosen to waive the time period allotted for considering this Separation Agreement.  Executive acknowledges and understands that revocation must be accomplished
      by a written notification to the Company’s Chief Executive Officer that is received prior to the Effective Date.  The Parties agree that changes to this
      Separation Agreement, whether material or immaterial, do not restart the running of the 21-day consideration period referenced above.

  

  

  7. Unknown Claims. Executive acknowledges that he has been
      advised to consult with legal counsel and that he is familiar with the principle that a general release does not extend to claims that the releaser does not know or suspect to exist in his favor at the time of executing the release, which, if known
      by him, must have materially affected his settlement with the releasee.  Executive, being aware of said principle, agrees to expressly waive any rights he may have to that effect, as well as under any other statute or common law principles of similar
      effect.

  

  

  8. No Pending or Future Lawsuits.  Executive represents
      that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that he does not intend to bring any claims on his own behalf or
      on behalf of any other person or entity against the Company or any of the other Releasees.

  

  

  9. Confidentiality.  Subject to the Protected Activity
      Section below, Executive agrees to maintain in complete confidence the existence of this Separation Agreement, the contents and terms of this Separation Agreement, and the consideration for this Separation Agreement (hereinafter collectively referred
      to as “Separation Information”). Except as required by law, Executive may disclose Separation Information only to Executive’s immediate family members, the Court in any proceedings to enforce the terms of this Separation Agreement, Executive’s
      attorney(s), and Executive’s accountant(s) and any professional tax advisor(s) to the extent that they need to know the Separation Information in order to provide advice on tax treatment or to prepare tax returns, and must prevent disclosure of any
      Separation Information to all other third parties. Executive agrees that Executive will not publicize, directly or indirectly, any Separation Information.  The Company hereby grants Executive consent to notify bona fide prospective and actual
      employers or business partners of his obligations under the Confidentiality Agreement.

  

  

  10. Non-Competition, Non-Solicitation, Non-Interference, and
          Confidential Information.  Executive reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreement, a copy of which is enclosed with this Transition Agreement as Exhibit A, specifically including the provisions therein regarding non-disclosure of the Company’s trade secrets and confidential and proprietary information, and Executive’s non-competition,
      non-solicitation, and non-interference obligations. Executive hereby grants consent to notification by the Company to any new employer about his obligations under the
        Confidentiality Agreement and this Section. Executive’s signature below constitutes Executive’s certification under penalty of perjury that Executive has returned all documents and other items provided to Executive by the Company (with the
      exception of the Company-owned laptop computer issued to Executive during his employment, as provided in Section 1(f), and a copy of personnel documents specifically relating to Executive), developed or obtained by Executive in connection with
      Executive’s employment with the Company, or otherwise belonging to the Company.

  
    13

    
      

  

  
  11. No Cooperation.  Subject to the Protected Activity
      provision below, Executive agrees that he will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party
      against any of the Releasees, unless under a subpoena or other court order to do so or upon written request from an administrative agency or the legislature or as related
        directly to the ADEA waiver in this Separation Agreement. Executive agrees both to promptly notify the Company upon receipt of any such subpoena or court
      order or written request from an administrative agency or the legislature, and to furnish, within five (5) business days of its receipt, a copy of such subpoena or
      other court order or written request from an administrative agency or the legislature. If approached by anyone for counsel or assistance in the presentation or
      prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall state no more than that he cannot provide counsel or assistance.

  

  

  12. Protected Activity Not Prohibited.  Executive
      understands that nothing in this Separation Agreement, or any other agreement or policy of the Company, shall in any way limit or prohibit Executive from engaging in any Protected Activity. Protected Activity includes filing and/or pursuing a charge,
      complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (“Government
      Agencies”). Executive understands that in connection with such Protected Activity, he is permitted to disclose documents or other information as permitted by law, without giving notice to, or receiving authorization from, the Company. Notwithstanding
      the foregoing, Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company Confidential Information to any parties other than the Government Agencies. Executive
      further understands that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications or attorney work product. In
        addition, pursuant to the Defend Trade Secrets Act of 2016, Executive is notified that an individual will not be held criminally or civilly liable under any
        federal or state trade secret law for the disclosure of a trade secret that (a) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (b) is made in a
        complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may
        disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant
        to court order.

  

  

  13. Mutual Nondisparagement. Executive agrees to refrain
      from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees. The Company agrees to refrain from making any
      disparaging statements about Executive. Executive understands that the Company’s obligations under this Section extend only to the Company’s current executive officers and members of its Board of Directors and only for so long as each officer or
      member is an employee or Director of the Company.

  

  

  14. No Admission of Liability.  Executive understands and
      acknowledges that with respect to all claims released herein, this Separation Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive unless such claims were explicitly not released by the
      release in this Separation Agreement. No action taken by the Company hereto, either previously or in connection with this Separation Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential
      claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.

  
    14

    
      

  

  15. Costs.  The Parties shall each bear their own costs,
      attorneys’ fees, and other fees incurred in connection with the preparation of this Separation Agreement.

  

  

  16. ARBITRATION.  EXCEPT AS PROHIBITED BY LAW, THE PARTIES
      AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS SEPARATION AGREEMENT, THEIR INTERPRETATION, EXECUTIVE’S EMPLOYMENT WITH THE COMPANY OR THE TERMS THEREOF, OR ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION UNDER
      THE FEDERAL ARBITRATION ACT (THE “FAA”) AND THAT THE FAA SHALL GOVERN AND APPLY TO THIS ARBITRATION AGREEMENT WITH FULL FORCE AND EFFECT; HOWEVER, WITHOUT LIMITING ANY PROVISIONS OF THE FAA, A MOTION OR PETITION OR ACTION TO COMPEL ARBITRATION MAY
      ALSO BE BROUGHT IN STATE COURT UNDER THE PROCEDURAL PROVISIONS OF SUCH STATE’S LAWS RELATING TO MOTIONS OR PETITIONS OR ACTIONS TO COMPEL ARBITRATION. EXECUTIVE AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, EXECUTIVE MAY BRING ANY SUCH
      ARBITRATION PROCEEDING ONLY IN EXECUTIVE’S INDIVIDUAL CAPACITY. THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN
      TRAVIS COUNTY, TEXAS BEFORE JUDICIAL ARBITRATION & MEDIATION SERVICES, INC. (“JAMS”), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (“JAMS RULES”).  THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES.  THE
      ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH TEXAS LAW, INCLUDING THE TEXAS RULES OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL TEXAS LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY
      CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH TEXAS LAW, TEXAS LAW SHALL TAKE PRECEDENCE.  THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION. 
      THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD.  THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS
      AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. 
      NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS
      AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION
      AGREEMENT SHALL GOVERN.

  

  

  17. Tax Consequences.  The Company makes no representations
      or warranties with respect to the tax consequences of the payments and any other consideration provided to Executive or made on Executive’s behalf under the terms of this Separation Agreement. Executive agrees and understands that Executive is
      responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Executive further agrees to indemnify and hold the
      Releasees harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Executive’s failure to pay or
      delayed payment of federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs. The Parties agree and acknowledge that the payments made pursuant to Section 1 of this Separation
      Agreement are not related to sexual harassment or sexual abuse and not intended to fall within the scope of 26 U.S.C. Section 162(q).

  
    15

    
      

  

  
  18. Section 409A.  It is intended that this Separation
      Agreement comply with, or be exempt from, Code Section 409A and the final regulations and official guidance thereunder (“Section 409A”) and any ambiguities herein will be interpreted to so comply and/or be exempt from Section 409A. Each payment and
      benefit to be paid or provided under this Separation Agreement is intended to constitute a series of separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.  The Company and Executive will work together in good faith to
      consider either (a) amendments to this Separation Agreement; or (b) revisions to this Separation Agreement with respect to the payment of any awards, which are necessary or appropriate to avoid imposition of any additional tax or income recognition
      prior to the actual payment to Executive under Section 409A. In no event will the Releasees reimburse Executive for any taxes that may be imposed on Executive as a result of Section 409A.

  

  

  19. Authority.  The Company represents and warrants that the
      undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Separation Agreement. Executive represents and warrants that he has the capacity to act on his
      own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Separation Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or
      otherwise of or against any of the claims or causes of action released herein.

  

  

  20. Severability.  In the event that any provision or any
      portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Separation Agreement shall continue in full force and
      effect without said provision or portion of provision.

  

  

  21. Entire Agreement. This Separation Agreement represents the
        entire agreement and understanding between the Company and Executive concerning the subject matter of this agreement and the events leading thereto and associated
        therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter herein and Executive’s relationship with the Company, with the exception of the Confidentiality Agreement and the Equity
      Agreements.  Notwithstanding anything to the contrary herein, this Separation Agreement does not supersede or replace the Indemnification Agreement or any law,
      bylaw, article of incorporation or insurance policy that provides Executive a right to indemnification, defense, advancement, or insurance coverage.

  

  

  22. No Oral Modification.  This Separation Agreement may
      only be amended in a writing signed by Executive and the Company’s Chief Executive Officer.

  

  

  23. Governing Law.  This Separation Agreement shall be
      governed by the laws of the State of Texas, without regard for choice-of-law provisions, except that any dispute regarding the enforceability of the Arbitration Section of this Separation Agreement shall be governed by the FAA. Executive consents to
      personal and exclusive jurisdiction and venue in the State of Texas.

  

  

  24. Effective Date.  Executive understands that this
      Separation Agreement shall be null and void if not executed by Executive within twenty-one (21) days from Executive’s Separation Date. If for any reason Executive terminates employment before the Separation Date, Executive shall execute this this
      Separation Agreement within twenty-one (21) days from Executive’s actual date of separation of employment. Each Party has seven (7) days after that Party signs this Separation Agreement to revoke it. This Separation Agreement will become effective on
      the eighth (8th) day after Executive signed this Separation Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”).

  
    16

    
      

  

  
  25. Counterparts.  This Separation Agreement may be executed
      in counterparts and each counterpart shall be deemed an original and all of which counterparts taken together shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the
      undersigned.  The counterparts of this Separation Agreement may be executed and delivered by facsimile, photo, email PDF, or other electronic transmission or signature.

  

  

  26. Voluntary Execution of Agreement.  Executive understands
      and agrees that he executed this Separation Agreement voluntarily and without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Executive’s claims against the Company and
      any of the other Releasees. Executive acknowledges that: (a) he has read this Separation Agreement; (b) he has been represented in the preparation, negotiation, and execution of this Separation Agreement by legal counsel of Executive’s own choice or
      has elected not to retain legal counsel; (c) he understands the terms and consequences of this Separation Agreement and of the releases it contains; (d) he is fully aware of the legal and binding effect of this Separation Agreement; and (e) has not
      relied upon any representations or statements made by the Company that are not specifically set forth in this Separation Agreement.

  

  

  [SIGNATURE PAGE FOLLOWS]

  
    17

    
      

  

  IN WITNESS WHEREOF, the Parties have executed this Separation Agreement on the respective dates set forth below.

   

  

   

  

   

  

  

  

  
    	
             

          	
            JASON GREEN, an individual

          
	
             

          	
             

          
	
            Dated: _________________

            

          	 	
             

          
	 	
            Jason Green

          	 

    

    

    

    

    

    

    

    

    	 	
             

          	
            NATIONAL INSTRUMENTS CORPORATION

          
	 	
             

          	
             

          
	
            Dated: _________________

          	
            By:

          	 	
             

          
	 	
             

          	
            Eric Starkloff

            Chief Executive Officer

          

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  Signature Page to Separation Agreement

   

  

  18EXHIBIT 10.1

EMPLOYMENT AND NON-COMPETITION AGREEMENT

 

This EMPLOYMENT
AND NON-COMPETITION AGREEMENT (this “Agreement”), dated as of November 15, 2022 (the “Effective Date”), is among
CURO Group Holdings Corp., a Delaware corporation (“CURO”), CURO Management LLC, a Nevada limited liability company (“CMLLC”),
and Douglas Clark (“Employee”). As used in this Agreement, the terms “CURO” or the “Company” include
both CURO and CMLLC, unless the context clearly indicates otherwise.

 

1.       Employment.
As of the Effective Date, CURO hereby continues the employment of Employee, and Employee hereby accepts such continued employment, upon
the terms and subject to the conditions hereinafter set forth. Upon becoming effective, this Agreement supersedes and replaces in its
entirety (i) the Employment and Non-Competition Agreement between CURO and Employee dated December 27, 2021; (ii) the Employment Agreement
between SouthernCo Inc. and Employee dated July 31, 2020, as amended by an Amendment Agreement in February, 2021, and (iii) the Confidentiality,
Non-competition and Assignment Agreement between SouthernCo Inc. and Employee dated July 21, 2020 (collectively, the “Prior Agreements”).

 

2.       Duties.
Employee shall be employed as the Chief Executive Officer of CURO. In such capacity, Employee shall have the responsibilities and duties
customary for such office and such other executive responsibilities and duties as are reasonably assigned by the Board of Directors (the
“Board”) of CURO which are consistent with Employee’s position. At all times during the performance of this Agreement,
Employee will adhere to the rules and regulations (the “Policies”) that have been or may hereafter be established by the Board
(and any committee thereof) for the conduct of employees of CURO and its subsidiaries or for the position or positions held by Employee.
Employee agrees to devote substantially all of Employee’s time and best efforts to the performance of Employee’s duties to
CURO.

 

3.       Term.
Employee’s term of employment hereunder shall be effective as of the Effective Date and shall continue until terminated in accordance
with Section 6 below.

 

4.       Compensation
and Benefits. Until the termination of Employee’s employment hereunder, in consideration for the services of Employee, CURO
shall compensate Employee as follows:

 

(a)       Base
Salary. As referenced in the terms sheet dated November 11, 2022, and signed by Employee (the “Terms Sheet”), CURO shall
pay Employee, in accordance with CURO’s then current payroll practices, an annual base salary (the “Base Salary”). As
of the Effective Date, Employee’s Base Salary is $725,000. The Base Salary shall be periodically reviewed by CURO and may be increased
but not decreased.

 

(b)       Short-Term
Incentive Compensation. For each calendar year during the term of this Agreement, Employee shall be eligible to participate in
CURO’s annual short-term incentive program, with a target annual short-term incentive compensation award as determined
annually by the full Board (the “STIP Award”). Employee’s target 2023 STIP Award is set forth in the Terms Sheet.
Subject to the foregoing, the performance targets, allocation of the aggregate award among those performance targets and threshold
and stretch potential shall be approved annually by the 
 
    	 		 

     

    
    Board and shall be substantially similar to the terms and conditions
applicable to awards made to other executive officers. Any STIP Award actually earned by Employee in any calendar year shall be paid
to Employee at the same time and manner as CURO pays annual short-term incentive compensation awards to other executive officers,
subject to Employee’s employment through the applicable performance period.

 

(c)       Acquisition
RSU Grant. On December 27, 2021 (the “Acquisition Date”), Employee was granted $1,500,000 of CURO restricted stock units
(“RSUs”) (the “Acquisition Grant”). The Acquisition Grant was reflected in a Restricted Stock Unit Grant Notice,
which provides for vesting over three years beginning on the Acquisition Date in equal annual increments. Employee will forfeit any unvested
RSUs if Employee’s employment terminates prior to the vesting date(s) under the Acquisition Grant; provided, however, that if Employee’s
employment is terminated due to Employee’s death or Disability under Sections 6(a) or 6(b), by the Company under Section 6(d) or
by Employee under Section 6(e), the vesting of any unvested RSUs will accelerate and all unvested RSUs under the Acquisition Grant will
be vested as of Employee’s last date of employment.

 

(d)       Long-Term
Incentive Compensation. For each calendar year during the term of this Agreement, Employee shall be eligible to participate in CURO’s
long-term incentive compensation program (the “LTIP Award”). The LTIP Award shall be in the amount and form of equity (subject
to vesting and other terms) as determined annually by the full Board and shall be evidenced by an award agreement in the form used by
CURO for other senior executives. Employee’s target 2023 LTIP Award is set forth in the Terms Sheet.

 

(e)       Vacation.
Employee shall be part of CURO’s Flexible paid time off program which has no fixed number or predetermined amount of vacation or
sick days per year. Any vacation shall be taken at the reasonable and mutual convenience of CURO and Employee.

 

(f)       Stay
Bonus. Employee will receive a cash bonus in the amount of $500,000, subject to applicable federal, state and local tax withholding,
payable in a lump sum no later than January 26, 2023 (the “Key Date”). The stay bonus is conditional upon Employee remaining
an employee through the Key Date. If Employee’s employment is terminated due to Employee’s death or Disability under Sections
6(a) or 6(b), the Company terminates Employee’s employment pursuant to Section 6(d), or Employee terminates employment pursuant
to Section 6(e) prior to the Key Date, the stay bonus shall be considered earned by Employee and will be paid within 30 days of Employee’s
termination date.

 

(g)       Retention
Bonus. Employee remains eligible to participate in CURO’s 2022 retention program, subject to the terms and conditions thereof.

 

(h)       Insurance;
Other Benefits. Employee shall be entitled to receive any health, accident, disability and life insurance and other employee benefits
provided by CURO under group health, accident, disability and life insurance plans and other employee benefit plans and fringe benefits
maintained by CURO for its full-time, salaried executive employees as such benefits may be modified from time-to-time by the Board. In
addition, Employee shall be entitled to participate in CURO’s Non-Qualified Deferred Compensation Plan, on terms consistent
with other senior executives of CURO.

    	 		 

     

    
(i)       Withholding.
All amounts payable by CURO to Employee hereunder (including, but not limited to, Base Salary and STIP Award) shall be reduced prior to
the delivery of such payment to Employee by an amount sufficient to satisfy any applicable federal, state, local or other withholding
tax requirements.

 

5.       Expenses.
CURO shall reimburse Employee for all documented reasonable expenses of types authorized by CURO and incurred by Employee in the performance
of Employee’s duties hereunder. Employee shall comply with such budget limitations and approval and reporting requirements with
respect to expenses as CURO may establish from time-to-time.

 

6.       Termination.
Employee’s employment hereunder shall commence on the Effective Date and continue until the expiration of the term as contemplated
by Section 3 above, except that the employment of Employee hereunder shall earlier terminate:

 

(a)       Death.
Upon Employee’s death.

 

(b)       Disability.
At the option of CURO, in the event of Employee’s Disability (as defined below), upon 30 days’ written notice from CURO.
For purposes hereof, Employee shall be deemed to have a “Disability” if Employee is unable (as reasonably determined in good
faith by the Board), on account of a physical or mental illness, injury or disease or combination thereof, to substantially perform Employee’s
material duties and obligations under this Agreement for a period of more than 90 consecutive days or for a total of 180 days within any
12-month period.

 

(c)       For
Cause. For “Cause” immediately upon written notice by CURO to Employee. For purposes of this Agreement, a termination
shall be for Cause if the Board shall reasonably determine, that any one or more of the following has occurred:

 

       (i)       Employee
shall have committed an act of fraud, embezzlement, misappropriation or breach of fiduciary duty against CURO or any of its subsidiaries
(CURO and all of its subsidiaries, collectively, the “Companies”), including, but not limited to, the offer, payment, solicitation
or acceptance of any unlawful bribe or kickback with respect to the business of any of the Companies;

 

       (ii)       Employee
shall have committed or been convicted by a court of competent jurisdiction of, or pleaded guilty or nolo contendere to, any felony or
any other crime that could reasonably be expected to have a material adverse effect on the business or reputation of any of the Companies;

 

       (iii)       Employee
shall have committed a material breach of any of the covenants, terms and provisions of Sections 7, 8 or 9 hereof or of CURO’s Code
of Business Conduct and Ethics or other written policy adopted by the Board;

 

       (iv)       Employee
shall have breached in any material respects any one or more of the provisions of this Agreement (excluding §§7, 8 and 9 hereof),
and such breach, if curable, shall have continued or not been remedied for a period of 10 days after written notice to Employee specifying
such breach in reasonable detail (and during which time Employee may be suspended with pay);

    	 		 

     

    

       (v)       Employee
shall have refused, after written notice, to obey any lawful resolution of or direction by the Board which is consistent with Employee’s
duties hereunder;

 

       (vi)       Employee
shall be chronically absent from work (excluding disability (as defined in the applicable plan or program), vacation, illnesses or leaves
of absence approved by the Board) and such absence shall continue following written notice to Employee;

 

       (vii)       Employee,
subject to Section 1 hereof, shall have failed to devote substantially all of Employee’s full time and best efforts to the
performance of Employee’s duties to CURO and such failure continues for more than 10 days after written notice of such failure
has been given to Employee; or

 

       (viii)       Employee
shall have engaged in the unlawful use (including being under the influence) or possession of illegal drugs or shall have possessed illegal,
unpermitted or unregistered weapons, in each case on the premises of CURO or any of its direct or indirect subsidiaries.

 

(d)       Resignation
or Termination Without Cause. At any time, upon written notice by either CURO or Employee to the other party hereto.

 

(e)       Resignation
For Good Reason. Employee may terminate employment for “Good Reason” upon prior written notice to CURO, provided that
(x) such notice shall be provided by Employee no later than 90 days after the applicable Good Reason event, (y) CURO shall have an opportunity
to cure for a period of 30 days (or shorter period as provided below), and (iii) such termination of employment shall occur no later than
90 days after CURO has failed to cure. For purposes of this Agreement, the term “Good Reason” shall mean:

 

       (i)       a
material breach by CURO of any of its obligations under this Agreement that shall have continued for a period of 30 days after written
notice to CURO specifying such breach in reasonable detail and that is continuing as of the date of termination; or

 

       (ii)       any
other action by CURO which results in a material diminution in Employee’s title, position, compensation, status, reporting relationships,
authority, duties or responsibilities, other than insubstantial or inadvertent actions not taken in bad faith which are remedied by CURO
within 10 business days after receipt of notice thereof given by Employee. For purposes of the foregoing, (a) changes in the
reporting relationships of officers and management personnel other than the Chief Executive Officer shall not be deemed to constitute
a material diminution as long as all such officers and management personnel report to the Chief Executive Officer directly or through
one or more other officers or management personnel and (b) CURO and Employee acknowledge and agree that legal and compliance related
functions may be required to report to the Board or a committee thereof and that any such reporting arrangements will not constitute a
material diminution of reporting relationships.

 

    	 		 

     

    

(f)       Rights
and Remedies on Termination.

 

       (i)       If
Employee’s employment hereunder is terminated for any reason (including those reasons specified in Sections 6(a) through 6(e)),
then Employee (or Employee’s estate, as applicable) shall be entitled to receive (i) any accrued but unpaid Base Salary through
the date of termination of employment, (ii) any accrued but unused vacation time through the date of termination of employment, subject
to and in accordance with all applicable CURO policies, (iii) reimbursement for any unreimbursed business expenses incurred through the
date of termination of employment, and (iv) all other compensatory payments and employee benefits to which Employee is entitled upon termination
of employment under the terms of any compensatory arrangement or employee benefit plan (collectively, the “Accrued Obligations”).

 

       (ii)       If
Employee’s employment hereunder is terminated by CURO pursuant to Section 6(d) or by Employee pursuant to Section 6(e), then Employee
shall be entitled to receive, in addition to the Accrued Obligations, (a) payment, in accordance with CURO’s then-current payroll
practices, of Employee’s Base Salary in effect at the time of such termination (the “Termination Date”) for a 12-month
period following such termination (the “Severance Period”), (b) any STIP Award earned for a completed calendar year pursuant
to Section 4(b) but not yet paid as of the Termination Date, (c) to the extent that the Board determines that CURO was on track to
meet the current calendar year STIP Award targets contemplated by Section 4(b) at the Termination Date and those targets are actually
met for such calendar year, the amount of the applicable STIP Award prorated for the number days elapsed (out of 365) in such year prior
to such Termination Date (it being understood and agreed that any STIP Award or prorated STIP Award payable pursuant to clauses (b) or
(c) above shall be paid at such time as such STIP Awards would have otherwise been payable under Section 4(b)) and (d) to the extent
permitted by applicable law without any penalty to Employee or CURO and subject to Employee’s election of COBRA continuation coverage
under CURO’s group health plan for Employee and/or Employee’s spouse or other eligible dependents, on the first regularly
scheduled payroll date of each month of the Severance Period during which Employee and/or Employee’s spouse or eligible dependents
are receiving COBRA continuation coverage under CURO’s group health plan (the “COBRA Continuation Period”), CURO will
pay Employee an amount equal to the “applicable percentage” of the monthly COBRA premium cost for such coverage; provided
that the payments pursuant to this clause (d) shall be made on an after-tax basis and cease earlier than the expiration of the COBRA Continuation
Period in the event (and to the extent) that Employee becomes eligible to receive any health benefits, including through a spouse’s
employer, during the COBRA Continuation Period or Employee and/or Employee’s spouse or other eligible dependents otherwise cease
receiving COBRA continuation coverage. For purposes hereof, the “applicable percentage” shall be the percentage of Employee’s
health care premium costs for the applicable coverage that is paid by CURO as of the date of termination. Notwithstanding the foregoing,
(x) Employee’s right to receive the foregoing payments and benefits is expressly conditioned upon receipt by CURO, within the
time frame specified by Section 11(i)(iv), of a written release executed by Employee, in form and substance reasonably satisfactory to
CURO, of any and all claims or causes of action of any nature relating directly or indirectly to such Employee’s employment or termination
of employment by CURO, and (y) in the event that Employee breaches any of the covenants, terms or provisions of Sections 7, 8 or
9 hereof, without limiting any other rights that CURO may have, CURO’s obligation to make payments under this Section 6(f)(ii) shall
immediately terminate.

 

    	 		 

     

    
(iii)        In
the event any payments or benefits otherwise payable to Employee, whether or not pursuant to this Agreement, (a) constitute
“parachute payments” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”),
and (b) but for this Section 6(f)(iii), would be subject to the excise tax imposed by Section 4999 of the Code, then such payments and
benefits will be either (x) delivered in full, or (y) delivered as to such lesser extent that would result in no portion of such payments
and benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable
federal, state and local income and employment taxes and the excise tax imposed by Section 4999 of the Code (and any equivalent state
or local excise taxes), results in the receipt by Employee on an after-tax basis, of the greatest amount of benefits, notwithstanding
that all or some portion of such payments and benefits may be taxable under Section 4999 of the Code. Unless CURO and Employee otherwise
agree in writing, any determination required under this Section 6(f)(iii) will be made in writing by the public accounting firm that is
retained by CURO as of the date immediately prior to the change in control (“Accountants”). In the event that the Accountants
are serving as accountant or auditor for the individual, entity, or group effecting the change in control, Employee will appoint another
nationally recognized public accounting firm to make the determinations required hereunder (which accounting firm will then be referred
to as the “Accountants”). The determination of the Accountants will be conclusive and binding upon Employee and CURO for all
purposes. For purposes of making the calculations required by this Section 6(f)(iii), the Accountants (1) may make reasonable assumptions
and approximations concerning applicable taxes, (2) may rely on reasonable, good faith interpretations concerning the application of Sections
280G and 4999 of the Code, and (3) shall take into account a “reasonable compensation” (within the meaning of Q&A-9 and
Q&A-40 to Q&A 44 of the final regulations under Section 280G of the Code) analysis of the value of services provided or to be
provided by Employee, including any agreement by Employee (if applicable) to refrain from performing services pursuant to a covenant not
to compete or similar covenant applicable to Employee that may then be in effect (including, without limitation, those contemplated by
Section 8 of this Agreement). CURO and Employee agree to furnish to the Accountants such information and documents as the Accountants
may reasonably request in order to make a determination under this provision. CURO will bear all costs the Accountants may reasonably
incur in connection with any calculations contemplated by this provision.

 

To the extent such aggregate parachute
payment amounts are required to be so reduced, the parachute payment amounts due to Employee (but no non-parachute payment amounts) shall
be reduced in the following order: (A) the parachute payments that are payable in cash shall be reduced (if necessary, to zero) with amounts
that are payable last reduced first; (B) payments and benefits due in respect of any equity, valued at full value (rather than accelerated
value) (as such values are determined under Treasury Regulation Section 1.280G-1, Q&A 24) shall be reduced in each case in reverse
order beginning with payments or benefits which are to be paid the furthest in time; and (C) all other non-cash benefits not otherwise
described in clause (B) of this Section 6(f)(v) reduced last. In applying these principles, any reduction or elimination of the payments
shall be made in a manner consistent with the requirements of Section 409A of the Code and where two economically equivalent amounts are
subject to reduction but payable at different times, such amounts shall be reduced on a pro rata basis but not below zero.

 

    	 		 

     

    
       (iv)       Except
as otherwise set forth in this Section 6(f) and Sections 4(c) and 4(f), Employee shall not be entitled to any severance, bonus or other
compensation after termination of employment.

 

7.       Inventions;
Assignment. All rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto)
related to the business of any of the Companies, whether or not patentable, copyrightable, registrable as a trademark or reduced to writing,
that Employee may discover, invent or originate during the term of Employee’s employment hereunder, either alone or with others
and whether or not during working hours or by the use of the facilities of any of the Companies (“Inventions”), shall be the
exclusive property of the Companies. Employee shall promptly disclose all Inventions to CURO, shall execute at the request of CURO any
assignments or other documents CURO may deem necessary to protect or perfect the rights of the Companies therein, and shall assist the
Companies, at the Companies’ expense, in obtaining, defending and enforcing the Companies’ rights therein. Employee hereby
appoints CURO and each of the other Companies, individually, as Employee’s attorney in fact to execute on Employee’s behalf
any assignments or other documents deemed necessary by CURO or any of the other Companies to protect or perfect their rights to any Inventions.

 

8.       Confidential
Information. 

(a)             
Employee recognizes and acknowledges that certain assets of, and information relating to, the Companies,
including, without limitation, information regarding the Companies’ methods of operation, financial information, strategic planning,
operational budgets and strategies, payroll data, management systems programs, computer systems, marketing plans and strategies, merger
and acquisition strategies and customer lists (“Confidential Information”) are valuable, special and unique assets or information
of the Companies and their affiliates. Employee shall not, during or after Employee’s term of employment, disclose any or any part
of the Confidential Information to any person, firm, corporation, association or any other entity for any reason or purpose whatsoever,
directly or indirectly, except as may be required pursuant to Employee’s employment hereunder; provided, that Confidential Information
shall in no event include (i) Confidential Information which was generally available to the public at the time of disclosure by Employee
or (ii) Confidential Information which becomes publicly available other than as a consequence of the breach by Employee of Employee’s
confidentiality obligations hereunder. In the event of the termination of Employee’s employment, whether voluntary or involuntary
and whether by CURO or Employee, Employee shall deliver to CURO all documents and data pertaining to the Confidential Information and
shall not take with Employee any documents or data of any kind or any reproductions (in whole or in part) or extracts of any items relating
to the Confidential Information. In the event that Employee is legally compelled to disclose any of the Confidential Information, Employee
shall provide CURO with prompt written notice so that CURO, at its sole cost and expense, may seek a protective order or other appropriate
remedy and/or waive compliance with the provisions of this Agreement. In the event that such protective order or other remedy is not obtained,
or that Employer waives compliance with the provisions of this Agreement, Employee shall furnish only that portion of the Confidential
Information that Employee is advised by counsel is legally required to be disclosed.

(b)            
In addition, Employee understands that nothing in this Agreement shall be construed to prohibit Employee
from (i) filing a charge or complaint with, participating in an 

    	 		 

     

    
    investigation or proceeding conducted by, or reporting possible violations
of law or regulation to any federal, state or local government agency, (ii) truthfully responding to or complying with a subpoena, court
order or other legal process or (iii) exercising any rights Employee may have under applicable labor laws to engage in concerted
activity with other employees; provided however, that Employee agrees to forgo any monetary benefit from the filing of a charge or complaint
with a government agency except pursuant to a whistleblower program or where Employee’s right to receive such a monetary benefit
is otherwise not waivable by law.

 

(c)            
Employee understands that the Defend Trade Secrets Act provides that Employee may not
be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in
confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, and solely for the purpose
of reporting or investigating a suspected violation of law; or that is made in a complaint or other document filed in a lawsuit or other
proceeding, if such filing is made under seal. In the event that Employee files a lawsuit for retaliation by any of the Companies for
reporting a suspected violation of law, Employee may disclose the trade secret to Employee’s attorney and use the trade secret information
in the court proceeding, if Employee files any document containing the trade secret under seal and does not disclose the trade secret,
except pursuant to court order.

 

9.       Post
Termination Covenants. During the term of Employee’s employment hereunder and for 12 months (“the Designated Period”)
after termination of Employee’s employment hereunder, Employee will not (a) anywhere within any county in which any of the
Companies conducts business, engage, directly or indirectly, alone or as a shareholder (other than as a holder of less than 1% of the
common stock of any publicly traded corporation), partner, officer, director, employee, consultant or advisor, or otherwise in any way
participate in or become associated with, any other business organization that is engaged or becomes engaged in any business that provides
the same or any substantially similar services or products offered by any of the Companies during the term of Employee’s employment
or at the time of Employee’s termination or that any of the Companies has notified Employee at any time prior to the time of such
termination that it proposes to conduct and for which any of the Companies have, prior to the time of such termination, expended substantial
resources (the “Designated Industry”), (b) solicit any employee of any of the Companies to leave its employ for alternative
employment, or hire or offer employment to any person to whom Employee actually knows any of the Companies has offered employment, (c)
solicit, or attempt to divert or otherwise interfere with the relationship with, any customers or suppliers of the Companies, and (d)
disparage the Companies or any of their officers, directors or employees other than in the performance of Employee’s duties to the
Companies. For purposes of this Section 9 only, the term “Companies” shall apply only to CURO and any subsidiary of CURO for
which Employee has provided material services or obtained material Confidential Information. Employee acknowledges that the provisions
of this Section 9 are essential to protect the business and goodwill of the Companies. Employee will continue to be bound by the provisions
of this Section §9 until their expiration and shall not be entitled to any compensation from CURO with respect thereto except as
provided above. If at any time the provisions of this Section 9 shall be determined to be invalid or unenforceable by reason of being
vague or unreasonable as to area, duration or scope of activity, this Section 9 shall be considered divisible and shall become and be
immediately amended to only such area, duration and scope of activity as shall be determined to be reasonable and enforceable by the court
or other body having jurisdiction over the matter; and Employee agrees that this Section 9 as so amended shall be valid and binding as
though any 

    	 		 

     

    
    invalid or unenforceable provision had not been included herein. Employee hereby acknowledges that Employee has agreed to be
bound by the provisions of this Section 9 in consideration for the compensation, severance and other benefits to be provided by CURO to
Employee pursuant to the terms of this Agreement.

 

10.       Recoupment.
Any compensation paid or payable under this Agreement or any other agreement or arrangement between the
Employee and CURO shall be subject to any policy of CURO regarding the recoupment or clawback of compensation as in effect at the date
of this Agreement or as hereafter adopted or amended by the Board or required by applicable law, including to conform to regulations related
to recoupment or clawback of compensation adopted pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.

 

11.       General.

 

(a)       Notices.
All notices and other communications hereunder shall be in writing or by written telecommunication, and shall be deemed to have been duly
given if delivered personally or if mailed by certified mail, return receipt requested, postage prepaid or sent by written telecommunication
or telecopy, to the relevant address set forth below, or to such other address as the recipient of such notice or communication shall
have specified to the other party hereto in accordance with this Section 10(a):

 

If to CURO, to:

 

CURO Group Holdings Corp.

3615 North Ridge Road

Wichita, Kansas 67205

Attention: Chief Legal Officer

 

If to Employee, to Employee’s
last known address, as reflected in CURO’s records.

 

(b)       Equitable
Remedies. Each of the parties hereto acknowledges and agrees that upon any breach by Employee of Employee’s obligations under
Sections 7, 8 and 9 hereof, CURO will have no adequate remedy at law, and accordingly will be entitled to specific performance and other
appropriate injunctive and equitable relief.

 

(c)       Severability.
If any provision of this Agreement is or becomes invalid, illegal or unenforceable in any respect under any law, the validity, legality
and enforceability of the remaining provisions hereof shall not in any way be affected or impaired.

 

(d)       Waivers.
No delay or omission by either party hereto in exercising any right, power or privilege hereunder shall impair such right, power or privilege,
nor shall any single or partial exercise of any such right, power or privilege preclude any further exercise thereof or the exercise of
any other right, power or privilege.

 

(e)       Counterparts.
This Agreement may be executed in multiple counterparts (including by telecopier), each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument.

 

    	 		 

     

    
(f)       Assigns.
This Agreement shall be binding upon and inure to the benefit of the heirs and successors of each of the parties hereto, including any
entity which acquires substantially all of the assets or stock of CURO.

 

(g)       Entire
Agreement. This Agreement, together with the Terms Sheet and the documents containing the terms and conditions of the STIP Award,
LTIP Award, and RSU Grant referenced in each, contain the entire understanding of the parties and supersedes all prior agreements and
understandings relating to the subject matter hereof, including, without limitation, the Prior Agreements and any other employment agreements
or any other agreements or memoranda entitling Employee to compensation (including any bonus, but excluding the commitments regarding
2022 bonuses and 2022 long-term incentive awards made in the offer letter between Employee and CURO that was effective upon the Acquisition
Date and any awards and grants for which Employee remains eligible under the 2022 retention bonus program) from CURO or any of the Companies.
This Agreement shall not be amended except by a written instrument hereafter signed by each of the parties hereto.

 

(h)       Governing
Law. This Agreement and the performance hereof shall be construed and governed in accordance with the laws of the State of Kansas,
without giving effect to any principles of conflicts of laws.

 

(i)       Section
409A.

 

       (i)       Purpose.
This Agreement is intended to be exempt from Section 409A of the Internal Revenue Code of 1986, as amended and the rules and regulations
promulgated thereunder (collectively, “Section 409A”), to the fullest extent possible, partially as an involuntary separation
pay plan as that term is understood under Treasury Regulation § 1.409A-1(b)(9) and partially as providing for short-term deferrals
as that term is understood under Treasury Regulation § 1.409A-1(b)(4) and will be interpreted and operated consistently with those
intentions. If an amount is to be paid under this Agreement in two or more installments, each installment shall be treated as a separate
payment for purposes of Section 409A. To the extent Section 409A is found to be applicable to this Agreement, this Agreement is to be
interpreted to comply with Section 409A and will be interpreted and operated consistently with those intentions. However, CURO does not
warrant to Employee that all compensation paid or delivered to Employee for Employee’s services will be exempt from, or paid in
compliance with, Section 409A.

 

       (ii)       Amounts
Payable on Account of Termination. CURO will pay and provide Employee with the payments and benefits provided for under Section 6
of the Agreement if Employee’s employment terminates during the term of this Agreement in a manner that constitutes a “separation
from service” as that term is defined by Section 409A.

 

       (iii)       Reimbursements.
Any taxable reimbursement of business or other expenses as specified under this Agreement shall be subject to the following conditions:
(1) the expenses eligible for reimbursement in one taxable year shall not affect the expenses eligible for reimbursement in any other
taxable year; (2) the reimbursement of an eligible expense shall be 

    	 		 

     

    
    made no later than the end of the year after the year in which
such expense was incurred; and (3) the right to reimbursement shall not be subject to liquidation or exchange for another benefit.

 

       (iv)       Releases.
Any amounts otherwise payable on account of Employee’s separation from service under this Agreement which (1) are conditioned
in any part on a release of claims and (2) would otherwise be paid (assuming the release is given) prior to the last day on which
the release could become irrevocable assuming Employee’s latest possible execution and delivery of the release (such last day, the
“Release Deadline”) shall be paid, if ever, no sooner than the 60th day after Employee’s separation from
service, unless CURO elects to start such payments up to 30 days earlier.

 

       (v)       Interpretative
Rules. In applying Section 409A to amounts paid pursuant to this Agreement, any right to a series of installment payments under
this Agreement shall be treated as a right to a series of separate payments.

       (vi)       Delay
Period. Notwithstanding any other timing provision in this Agreement, if, at the time any payment that is not exempt from Section
409A would commence due to a separation from service, and Employee is a “specified employee” as that term is defined by Section
409A of the Code, then no such payment under this Agreement may be paid before the date that is six months after Employee’s separation
from service (or, if earlier, before the date of the individual’s death). Payments that are not exempt from Section 409A and that
Employee would otherwise have been entitled to during those six months will be accumulated and paid on the first payroll date after six
months following Employee’s separation from service (or, if earlier, following the individual’s death). All payments that
are exempt from Section 409A, or that would otherwise be made more than six months following Employee’s separation from service,
will be made in accordance with the general timing provisions described above.

 

[Remainder of page intentionally
left blank; signature page follows]

 

 

    	 		 

     

    
IN WITNESS WHEREOF, and intending to be legally
bound hereby, the parties hereto have caused this Agreement to be duly executed as of the date and year first above written.

	CURO GROUP HOLDINGS CORP.	EMPLOYEE 

                                        

	By:	/s/Rebecca Fox	 	By:	/s/
    Douglas Clark
	 	Rebecca Fox	 	 	Douglas Clark
	 	Chief Legal Officer	 	 	 
	 	 	 	 	 
	Date: 	November 14, 2022	 	Date:	November 14, 2022

 

	CURO MANAGEMENT LLC	  

                                      

	By:	/s/Rebecca Fox	 	
	 	Rebecca Fox	 	
	 	Authorized Officer	 	 
	 	 	 	 
	Date: 	November 14, 2022

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]